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SUMMARY
This study describes:
1. The isolation of total RNA and mRNA from Angora goat adrenals.
2. Synthesis and nucleotide sequence alignment of Angora goat CYPI7 cDNA. Two DNA
sequences were produced, identifying two CVP 17 alleles in an Angora goat from the
Swartland district.
3. The development of a CYPI7 genotype test for Angora goats.
4. Genotyping of Angora goats and Boer goats with the developed genotype test.
S. Mapping of the substituted amino acids in the amino terminal of CVP 17 to a specific
CYPI7 genotype.
6. Partial synthesis and alignment of Angora goat genomic nucleotide CYPI7 sequences.
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OPSOMMING
Hierdie studie beskryf:
1. Die isolering van totale RNA en mRNA van Angorabok byniere.
2. Sintese en nukleotied volgorde oplyning van Angorabok CYP17 eDNA. Twee DNA
volgordes is geproduseer, en so is twee CYP17 allele in 'n Angorabok van die Swartland
omgewing geïdentifiseer.
3. Die ontwikkeling van 'n CYP17 genotipe toets vir Angorabokke.
4. Genotipering van Angorabokke en Boerbokke met die ontwikkelde genotipe toets.
5. Korrelering van die omgeruilde aminosure in die aminoterminaal van CYPl7 met 'n
spesifieke genotipe.
6. Gedeeltelike sintese en oplyning van Angorabok genomiese CYPl7 nukleotied volgordes.
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CHAPTER 1
INTRODUCTION
The South African mohair industry supplies close to 50% of the world's mohair demand.
Furthermore, the South African Angora goat almost unarguably produces the best quality
mohair in the world. The South African Angora goat has been the topic of various research
projects due to the wide spread stress intolerant phenotype among farming stocks. The stress
intolerance of the Angora goat has many manifestations and places a serious burden on the
mohair industry in South Africa. It seems that inbreeding practices have for many years
caused the increased vulnerability to stress in these animals.
It is widely accepted that the breeding practices that produced the extraordinary quality of
fleece also yielded the stress intolerant phenotype, which is causing the significant stock
losses during cold spells. More than three decades ago VanRensburg concluded that
abnormally low levels of adrenal function in the Angora goat, coupled with qualitative
changes in steroid hormone biosynthesis, were responsible for the stress intolerance in these
animals [1]. One of the main manifestations of this intolerance is the inability of the Angora
goat to withstand exposure to extreme environmental conditions. Goats are especially
sensitive to the cold wet and windy weather that often prevails during winter months in the
Little Karoo and Eastern Cape where most Angora goat farming takes place in South Africa.
Comparison of the increase in plasma cortisol concentrations upon intravenous injection of
insulin among Angora goats and four other small ruminants showed that the Angora goat has
a significantly impaired cortisol response (fig.LI) [2]. Engelbrecht et al., in an in-depth study
of Angora goat adrenal steroidogenesis, postulated that the inability of the Angora goat to
produce sufficient cortisol could be the result of a shift in the flux of steroid intermediates
through the adrenal steroidogenic pathways [3]. In that study a malfunction at the level of the
hypothalamic-pituitary-adrenal axis (HPA-axis) was ruled out as a major cause of the
impaired cortisol response.
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Figure 1.1. Effect of insulin injection on cortisol production in five small stock breeds found
in South Africa (Herselman, personal communication).
Adrenal steroidogenesis is a complex process, regulated by morphological zonation of
steroid producing tissue together with cellular compartmentalization of the enzymes involved.
The steroids produced by the adrenal cortex have target tissues throughout the body and affect
sexual development and reproduction, intermediary metabolism and electrolyte balance.
These physiological functions are mediated mainly by three types of steroid hormones
produced by the adrenal cortex: 1) the mineralocorticoids, 2) the glucocorticoids and 3) the
androgens. Production of these hormones IS under strict hormonal control.
Adrenocorticotrophic hormone (ACTH) from the anterior pituitary is a 39 amino acid peptide
that binds to a transmembrane G-coupled protein receptor in all three zones of the adrenal
cortex [4]. ACTH action promotes the biosynthesis and release of various steroid hormones.
Chapter 2 gives a more detailed description of the regulation of adrenal steroidogenesis. The
activities and regulation of the enzymes involved in adrenal steroidogenesis have a huge
influence on the steroid hormone output of the adrenal cortex. Diseases such as congenital
adrenal hyperplasia (CAH), Cushing's syndrome and adrenogenital syndrome are a few of the
well-studied conditions caused by defects in enzymes catalyzing the steroid producing
reactions.
This thesis will address the role of cortisol in stress management and the biochemical
processes leading to its production. Cortisol is the main glucocorticoid in goat species [5].
The mediating capacity of cortisol in intermediary metabolism, especially in carbohydrate
metabolism, is well known. These properties of cortisol action are further discussed in
Stellenbosch University http://scholar.sun.ac.za
3Chapter 2. During periods of cold stress maintenance of blood glucose levels is crucial to
maintaining the mechanisms responsible for body heat production. These mechanisms are
compromised in the Angora goat due to the inability of the animal to maintain a sufficient
blood glucose concentration [6]. It is the aforementioned impaired cortisol response to HPA-
axis stimulation that is largely responsible for the rapid drop in blood glucose concentration in
the cold stressed Angora goat. In Chapter 3 adrenal steroidogenesis is discussed in more
detail. It is shown that the impaired cortisol response is caused by altered fluxes through the
steroid producing pathways. This alteration is the result of specificity and affinity differences
of steroid producing enzymes to certain intermediates.
The work of Engelbrecht et al. gave the first insights into the biochemical mechanisms of
Angora goat adrenal steroidogenesis [7]. It also indicated that one of the crucial enzymes
involved in adrenal steroidogenesis, cytochrome P450 17-a hydroxylasel17,20 lyase
(CYP17), was responsible for the decreased cortisol production of the Angora goat adrenal
cortex. In comparative studies with Angora goat, Boer goat and Merino sheep, Angora goats
were shown to produce more androgen precursors at the cost of glucocorticoid precursors
when compared to the other two species. CYP 17 is the only steroidogenic enzyme with dual
catalytic activity. Androgen production is dependent on the lyase action and glucocorticoid
production on the hydroxylation action of CYP 17. The differential regulation of these
activities has been the research focus in many studies investigating pubertal processes such as
adrenarche, which is dependent on increased androgen production from the adrenal [8].
Despite all the research on the stress intolerance of the Angora goat, the mohair farming
industry still lacks a feasible solution to their problem. According to experienced farmers in
the trade there are Angora goats that are markedly less susceptible to stress than others,
although they constitute the minority. Some breeders have been trying to breed hardened
Angora goat stocks by employing Mendelian selection strategies, looking for characteristics
they believe to confer stress tolerance. Such strategies, however, are proving unsuccessful
since the properties that constitute the proper fitness are not readily physically distinguishable
from those that do not.
The interesting observation by Engelbrecht et al. about the increased lyase activity of the
Angora goat adrenal CYP 17 prompted a further investigation of this important steroidogenic
cytochrome P450-dependent enzyme. It was decided to synthesize the cDNA of CYP17
through the reverse transcriptase polymerase chain reaction (RT-PCR) for expression in non-
steroidogenic tissue. This would enable reconstitution of CYP 17 away from its natural
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4environment where the activities of other steroidogenic enzymes, and cofactors like
cytochrome b5, complicates the interpretation of results. It would allow the investigation of
CYP17 activity and substrate specificity to determine the exact contribution of this enzyme to
the inability of the Angora goat to produce sufficient cortisol under stress conditions as shown
by Engelbrecht et al [3]. The isolation of total RNA and mRNA from the adrenal cortex of a
randomly selected Angora goat in the Western Cape is described in Chapter 4. The RNA
isolated was used to synthesize the cDNA of CYPI7 through a RT-PCR amplification.
Agarose gel and sequence analysis of the RT-PCR product showed the CYPI7 cDNA
synthesis to be successful. Sequence analysis of the RT-PCR product, however, revealed that
two copies of the Angora goat CVP 17 gene exist and that different CVP 17 genotypes could
thus exist in Angora goat populations. In addition a unique restriction endonuclease
recognition sequence was identified in one of the two CVP 17 alleles. Identification of a
second CYPI7 allele suggested one, or even two, of the possible CYPI7 genotypes to qualify
as a potential marker for hypoadrenocorticism in the Angora goat.
Since hypoadrenocorticism is caused by a very definite metabolic imbalance it is believed
to result from a genetic variation between goats that bear the symptoms of
hypoadrenocorticism and those that do not. It should therefore be possible to find such a
genetic marker and to employ it in breeding programs rather than the Mendelian breeding
strategies that have been employed so far. The CVP 17 genotype distribution among Angora
goats of different phenotypes believed to be influenced by CYPI7 activity was therefore
investigated. Analysis of the Angora goat CYPI7 cDNA gene structure also identified a
possible methodology for identifying different CVP 17 genotypes in Angora goats. The
difference in the restriction profile of the two CVP 17 alleles provided the basis for a genotype
test that could indicate the CVP 17 genotype of a goat.
The partial sequence analysis of the genomic copy of Angora goat CYPI7 is described in
Chapter 5. Comparisons were made with human and baboon genomic CVP 17 sequences. This
was done because genomic CVP 17 sequences were not available for either sheep or goat.
Analysis of the genomic CYPI7 gene structure together with the cDNA structure aided in the
development of a CYPI7 genotype test. The CYPI7 genotype test is fairly simple and is
based on the restriction enzyme analysis of a PCR fragment spanning the polymorphic region
of the genomic CVP 17 gene. The PCR product of this region is submitted to endonuclease
treatment with Acs I. This enzyme will cleave the PCR product to an extent determined by the
CYPI7 genotype due to the altered restriction enzyme profile mentioned earlier. Agarose gel
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5analysis of the PCR product digest with Acs I indicates the CYP17 genotype of the test
subject. A blood sample of less than 1 ml from each goat, is all that is required to perform the
genotype test.
Several Angora goats were subsequently genotyped in an effort to identify the different
CYP17 genotypes. A further aim was to find a possible correlation between a specific
genotype and a phenotype associated with the desired fitness traits. A total of 83 Angora goats
and six Boer goats were genotyped. Finally, in Chapter 7, the genotype results were discussed
in terms of the CYP17 allelic distribution and in terms of a correlation of the identified
genotypes with described phenotypes. Some suggestions are also made for utilizing the
CYP 17 genotype test in further investigations of the two CYP 17 allelic frequencies in
different Angora goat populations. The importance of further research on Angora goat CYP 17
activity in understanding the mechanism of hypoadrenocorticism is also emphasized.
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THE SOUTH AFRICAN ANGORA GOAT AND
ENVIRONMENTAL STRESS: A PHYSIOLOGICAL
PERSPECTIVE
2.1 Hypothalamic-pituitary-adrenal axis
Key to glucocorticoid, mineralocorticoid and androgen hormone homeostasis is the
integrity of the HPA-axis. The HPA-axis consists of three endocrine organs (hypothalamus,
pituitary and adrenal) and the hormones they produce. Interplay among these organs through
endocrine, paracrine and autocrine action of their hormones is essential to maintaining life.
Sexual maturation and reproduction [9], carbohydrate metabolism [10,11] and stress
management, and also salt balance of extracellular fluid (ECF) [12] are all controlled in part
by the integrated actions of adrenocortical hormones.
As mentioned earlier, in the South African Angora goat the stress management capabilities
are compromised to an extent due to a malfunction at some level of the HPA-axis [2]. This
manifests in the Angora goat's inability to cope with environmental extremes such as
exposure to wet and windy conditions with low temperatures. In the Little Karoo and Eastern
Cape, where most Angora goat farming takes place, these conditions are often encountered in
winter when surrounding mountains are covered in snow. These regions, however, offer the
best grazing to Angora goats. The HPA-axis will further be discussed in terms of the
hormones produced by the endocrine organs, their actions and regulation and some basic
anatomical features.
2.1.1 The hypothalamus
The hypothalamus is a complex brain structure forming part of the diencephalon and
consists of a variety of nuclei and nuclear areas. Many afferent and efferent neural pathways
connect the hypothalamus to many different centres in the central nervous system. These
include afferent pathways from the limbic lobe, midbrain, hippocampus, brain stem, medulla
and thalamus. Efferent pathways project from the hypothalamus to the limbic lobe, midbrain,
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7hippocampus, median emmence, pituitary stalk and posterior pituitary [13]. The
hypothalamus is central to a complex neural network that enables it to control the chemical
consistency and temperature of an organism. This chapter will focus on the regulation the
hypothalamus exerts through the pituitary to finally control the steroidogenic process in the
adrenal cortex. A diagrammatic representation of the human hypothalamus and pituitary gland
is shown in fig. 2.1.
Paraventricular nuc nucleus
Hypothalamus
Infundibulum
Hypothalamohypophyseal tract
Pars intermedia------+
Posterior
lobe
Anterior lobe
Figure 2.1. Human hypothalamus and pituitary. Reproduced from [14].
2.1.2 The pituitary
The pituitary gland consists of an anterior and posterior lobe. Nitric oxide containing
efferent nerves from the supraoptic and paraventricular hypothalamic nuclei innervate the
posterior lobe via the hypothalamohypophysial tract [15]. The anterior lobe has a vascular
connection with the hypothalamus and receives blood through the portal hypophyseal vessels
that drain the primary plexus of capillaries on the ventral surface of the hypothalamus [16].
These portal hypophyseal vessels then split up to form a capillary network that supplies the
anterior pituitary. The vascular connection between the hypothalamus and pituitary forms a
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8true portal system since it begins and ends with a capillary network without passing through
the heart. Various neurons from the hypothalamus that secrete hypophysiotrophic hormones
terminate in the median eminence and deliver their hormones to the primary plexus. These
hormones are subsequently transported through the hypophyseal portal system to their target
cells in the anterior pituitary.
The posterior pituitary mainly secretes vasopressin and oxytocin [17,18]. These hormones
are both nonapeptides that are produced in the cell bodies of the magnocellular neurons in the
supraoptic and paraventricular nuclei. They subsequently travel down the axons of these
neurons and are released from the nerve endings in the posterior pituitary lobe upon
depolarization of the neurons. Vasopressin (also called antidiuretic hormone - ADH) is
responsible for the re-uptake of water from the collecting ducts in the kidney by increasing
the permeability of the ducts to water [19,20].
Oxytocin increases contraction of smooth muscle in the breasts and uterus. Although many
hormones are responsible for breast development, milk production and secretion into the
ducts, ejection is dependent on oxytocin [21]. Anterior pituitary function is regulated by six
hypophysiotrophic hormones released from the hypothalamus into the primary plexus of the
median eminence.
These hormones are: corticotrophin-releasing hormone (CRH), thyrotrophin-releasing
hormone (TRH), growth hormone-releasing hormone (GRH), growth hormone-inhibiting
hormone (GIH or somatostatin), gonadotrophin-releasing hormone (GnRH) and prolactin-
inhibiting hormone (PIH) [22]. Binding of these hypothalamic hormones to their membrane
bound receptors in the anterior pituitary lead to the production and secretion of at least six
other hormones from specific cell types.
Five secretory cell types are found in the anterior pituitary. They are: somatotrophes
(growth hormone), lactotrophes (prolactin), thyrotrophes (thyroid-stimulating hormone -
TSH), gonadotrophes (luteinizing hormone - LH and follicle-stimulating hormone - FSH)
and corticotrophes (adrenocorticotrophic hormone - ACTH and ~-lipotrophin - ~-LPH) [12].
These hormones modulate reproductive, energy and growth metabolism to a great extent.
The hypothalamus receives a wide array of chemical and electrical stimuli sensing the
homeostatic status of an organism. In response to these stimuli it also generates chemical and
electrical signals. Many efferent neural pathways from the hypothalamus innervate the central
nervous system on different levels. Stimulating the pituitary also induces hormonal responses.
The hypothalamus thus is a centre for integrating the nervous and endocrine systems. This
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9integration enables an organism to react to changes in its environment, and to maintain
homeostasis. Only ACTH forms part of the HPA-axis, since the other hormones are not
known to affect adrenal activity significantly. Therefore only the effect of ACTH on the
adrenal, and the hypothalamic response to that, will further be discussed.
2.1.3. The role of glucocorticoids in HPA-axis regulation
Although CRH and ACTH can regulate adrenocortical function independent of
hypothalamic-pituitary innervation (section 2.2), the HPA-axis is central to modulating
adrenal steroidogenesis. Glucocorticoids released from the adrenal cortex in response to
ACTH have a negative feedback effect on the hypothalamic release of CRH. This effect is
mediated by binding of glucocorticoids to their receptors.
Glucocorticoid receptors are present in many tissues of the body. Two types of receptors
exist. The type II receptor is found throughout the brain, and is believed to play an important
role in mediation of the stress response. The abundant type II receptor is far from saturated,
even at high levels of circulating glucocorticoids [23]. The mineralocorticoid receptor (type I
receptor) is confined mainly to the hippocampus. These receptors are saturated at low levels
of circulating glucocorticoids, and are believed to restrict ACTH and CRH secretion during
the nadir of the circadian rhythm [24]. When glucocorticoid levels rise, ACTH secretion is
suppressed (fig. 2.2). This is the result of glucocorticoids acting on the hypothalamus and the
pituitary (inhibiting CRH release) [25]. Lowering of ACTH and CRH levels is achieved
through a fast feedback acting on the release of ACTH and CRH, and a longer term feedback
acting on the biosynthesis thereof. The mechanism of glucocorticoid action will be discussed
later in this chapter. There are two more important factors involved in regulating HPA-axis
activity: circadian rhythms (coupled to light dark cycles) and stress factors such as the
catecholamines. The mechanisms by which these factors regulate HPA-axis activity are not
fully elucidated, and are believed to differ among species.
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Figure 2.2. Diagram showing HPA-axis regulation. The Xs indicate the inhibiting influence
that free circulating glucocorticoids have on CRH and ACTH secretion.
2.2 Intra-adrenal regulatory mechanisms
ACTH binds to typical G-coupled transmembrane protein receptors in all three zones of
the adrenal. Adrenocortical steroidogenesis, however, is not solely controlled by the endocrine
actions of the hypothalamus and pituitary. Diurnal variation in adrenal steroidogenesis
persists in CRH knockout mice [26,27], indicating that a non-pituitary mediated mechanism
for controlling adrenal steroidogenesis could exist. The adrenal gland, as a functional unit,
consists of the inner medulla and the outer cortex. Although these were first thought to be two
very distinct and well-separated structures, it is today widely accepted that cells of both
structures are to be found in the other. Chromaffin cells from the medulla can be found as
single cells or islets in all three zones of the adrenal cortex [28]. Nets of chromaffin cells have
also been observed in the subcapsular region of the adrenal gland [29]. Similarly cortical cells
are found in the medulla. They are also seen as islets surrounded by chromaffin tissue while
some still have connections with the cortex [30]. This morphological arrangement ensures
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extensive contact areas between medullary and cortical cells enhancing paracrine signalling
between the two adrenal structures which forms the basis for intra-adrenal regulation of
medullary and cortical function.
2.2.1 Compounds from the medullary chromaffin cells
The main secretory products of the adrenal medulla are the catecholamines epinephrine,
nor-epinephrine and dopamine. There are, however, a number of other substances found in the
chromaffin cells of the medulla that could have regulatory effects on adrenal steroidogenesis.
Nor-epinephrine and epinephrine are secreted from the chromaffin cells in response to
stimulation by the splanchnic nerve [31]. These catecholamines stimulate the secretion of
cortisol, aldosterone and androstenedione if used to perfuse isolated porcine adrenal glands
[32]. Furthermore, catecholamines have a stimulatory effect on the transcription of certain
cytochrome P450 genes. As regulation on a transcriptional level is associated with long-term
rather than acute effects, the catecholamines are able to induce prolonged secretion of
corticosteroids from isolated adrenocortical cells [33].
Together with the catecholamines many different neurotransmitters, mostly peptides but
also serotonin, are secreted from the chromaffin cells, where they are also produced and
stored. Of these the enkephalins were discovered first and are also the most abundant
medullary neuropeptides [34]. Not all the peptides have stimulatory effects on
steroidogenesis, and they do not necessarily have the same action in different species. The
active neuropeptides and transmitters, released from either the chromaffin cells or the nerve
supply to the adrenal, form a diverse array of effectors. Amongst others, these effectors
orchestrate the complex machinery driving adrenal steroidogenesis.
Co-culture studies with bovine adrenomedullary chromaffin cells and bovine
adrenocortical cells established the paracrine effect chromaffin cells have on adrenocortical
cells [35]. Fig. 2.3 shows the amount of cortisol released from bovine cortical cells in
mono culture and in mixed culture with bovine chromaffin cells.
Different chromaffin cells exist in populations in the medulla with varying compositions of
neuropeptides. Independent mechanisms are responsible for the release of the different
peptides. These mechanisms are dependent on signaling molecules utilizing specific second
messengers and intracellular signaling pathways [36]. Humoral and immune factors, from
either intra-adrenal or extra-adrenal origin, can act as signaling molecules for the release of
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Figure 2.3. Cortisol release from primary cell cultures of bovine cortical cells alone (left) and
mixed with bovine chromaffin cells (right). Reproduced from [35].
the neuropeptides from the chromaffin cells. For example, interleukin-la (IL-la) and tumor
necrosis factor-a (TNF-a) differentially regulate Met-enkephalin, vasoactive intestinal
peptide (VIP), neurotensin and substance P biosynthesis in chromaffin cells [37].
The adrenocortical cells also produce the two aforementioned cytokines. Activity of the
adrenocortical cells can thus alter the composition of neuropeptides within the chromaffin
cells. A complete steroidogenic regulatory circuit therefore exists within the adrenal.
Although this might seem a very efficient regulatory mechanism, only a small number of
adrenocortical cells are in contact with medullary cells and a fast adrenocortical response
would not be possible through this mechanism. Gap junctions, however, circumvent this
problem. Gap junctions allow small water-soluble molecules to move quickly from the
cytoplasm of one cell to the next. This allows cellular signals to be passed from a stimulated
to an unstimulated cell. Gap junctions occur in all three zones of mammalian adrenal cortex
[38], and have been shown to form in both human and bovine primary adrenocortical cell
cultures [39].
2.2.2 Nerve supply to the adrenal cortex
It was believed many years ago that the adrenal cortex had no direct nerve supply. The
nerve supply to the medulla was thought to pass straight through the cortex without branching
in, or synapsing with cortical cells [40,41]. In 1971 Unsicker reported on the innervation of
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the rat and pig adrenal cortex [42]. Today the adrenal cortex is known to be innervated by a
rich nerve supply synapsing directly with steroid producing cells [43].
There are two distinct sources for the afferent innervation of the adrenal cortex. One is the
adrenal medulla. The cortex is believed to have been the target of medullary postganglionic
nerves before becoming more closely associated with the medulla during evolution. The
second source of nerve supply is uncertain. These nerves, however, have their cell bodies
outside the cortex and both post- and preganglionic fibres enter the cortex along blood
vessels.
Many different neurotransmitters are involved in relaying signals from the neural
component to the endocrine steroid producing cells. Peptidergic intrinsic nerves have been
described containing VIP, neuropeptide Y, substance P and calcitonin gene-related peptide
(CGRP) as neurotransmitters [44-46]. Catecholamines and acetylcholine have also been
identified as neurotransmitters in nerves supplying the cortex.
Regulation of the neural component controlling adrenal steroidogenesis, i.e. the
concentrations and ratios of different neurotransmitters, is complex and not well understood.
It is, however, safe to say that the physiological status of an organism plays a major role in
this regulation. In the same light it is difficult to say to what extent the splanchnic nerve
regulates neural activity in the cortex. Studies in different animal models have, however,
shown splanchnic nerve activity to increase adrenocortical sensitivity to ACTH stimulation
[47]. Severing the splanchnic nerve surgically causes decreased sensitivity of adrenocortical
cells to ACTH. The role of neural innervation of the adrenal cortex is probably best seen as
fine tuning adrenal steroidogenesis.
2.2.3 Vascularization of the adrenal gland
The steroid hormones produced and secreted by the adrenal cortex have target cells in
tissues throughout the body. These hormones have to travel along the vascular system in order
to reach their target cells. Therefore, the degree of vascularization of the adrenal gland plays a
vital role in the steroid delivering capacity of the gland. It is thus foreseeable that the adrenal
gland is a highly vascularized gland, receiving a comparatively large amount of the cardiac
output. Rat adrenals receive seven times more blood compared to the average blood to body
weight distribution ratio [48]. Fig. 2.4 is a diagrammatic presentation of adrenal
vascularization. In goats arterial blood is supplied from the renal and not the phrenic arteries
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[49]. Blood dissipates from these arteries into the subcapsular arteriolar plexus. From this
plexus blood either enters the thin walled sinusoids supplying the cortex, or the medullary
Medulla
'----Capsular artery
Corticalarteriole
Cortex
Zona
glornerutosa
Zona
Iasciculata
._- ......-----Cortical sinusoids
Zona
:Mcdullary "ein
Figure 2.4. Diagram illustrating the blood supply to the human adrenal gland. The region of
the capsule, the zones within the cortex, and the medulla are indicated. Reproduced from [14].
arteries that supply the medulla directly. The number of the medullary arteries varies between
species. This has implications for the regulation of blood flow through the gland and also for
the physiological requirements of an organism. It should be clear that the regulation of blood
flow through the adrenal is important in controlling steroid hormone balance throughout the
body.
As discussed earlier, both neural and endocrine mechanisms are involved in controlling
adrenal activity. Blood flow through the gland is also controlled by similar mechanisms.
Stellenbosch University http://scholar.sun.ac.za
15
Splanchnic nerve activity stimulates blood flow through the gland in dogs and calves [50,51].
This could be due to the release of neuropeptides.
Many of the neuropeptides mentioned earlier have been studied to determine their
influence on vasoconstriction or dilation. VIP, Met-enkephalin and CORP cause vasodilation,
while neuropeptide Y causes vasoconstriction [52,53]. Some neuropeptides were found to
have no vasoactive capacity, such as substance P, neurotensin and Leu-enkephalin. The
hypothalamic corticotrophe ACTH is also well known to affect blood flow through the
adrenal.
It was believed for some time that ACTH constricted the medullary arteries to increase
blood flow through the sinusoids in the cortex. However, in 1986, Hinson et al. showed that
ACTH administration to the perfused rat adrenal resulted in an overall increase of perfusion
medium flow rate [54]. Various other modulators of adrenal vasculature have been identified.
They include the secretory products of the vascular endothelium, namely nitric oxide,
endothelin 1 and adrenomedullin. In order for the blood flow rate to have a significant effect
on steroid delivery to target tissues, it would be expected that an increase in flow rate would
be met with an increase in steroid secretion.
Even if ACTH concentration were to remain constant, the rate of presentation to the target
cells in the cortex would increase with any increase in blood flow. Some researchers believe
this to be the main determinant for the amount of steroid secreted [55]. However, even in the
absence of ACTH there is an increase in corticosterone secretion of the isolated perfused rat
adrenal [54]. This effect is observed when flow rate is changed mechanically, or by the
addition of vasodilators. It is also only observed in the intact adrenal. This suggests that an
element that is lost when cells are dispersed, and which could therefore be a compound
released from the vascular endothelium, mediates this effect. Endothelial cell products not
only affect adrenal vasculature, but also modulate to some extent adrenocortical
steroidogenesis.
The vascularization of the adrenal cortex is such that almost every adrenocortical cell is
adjacent to a vascular endothelial cell. This arrangement is optimal for endothelial cells to
exert paracrine actions on adrenocortical cells. Endothelin 1 has more than one receptor and
binds to different subtypes. The distribution of these receptors through species and also the
different zones of the cortex vary. Endothelin 1 has been shown to stimulate aldosterone
secretion in some species. In bovine adrenal cell preparations endothelin 1 augments
angiotensin II and ACTH stimulated aldosterone secretion [56]. Nitric oxide has also been
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implicated as a modulator of adrenal steroidogenesis. Although nitric oxide does not influence
rat adrenal responsiveness to ACTH, basal levels of steroid output are much lower in the
absence of endogenous nitric oxide synthesis [57]. Adrenomedullin modulates aldosterone
secretion. There has, however, been some uncertainty over whether it inhibits or stimulates
aldosterone secretion. These discrepancies have been put down to the differential expression
of adrenomedullin receptors. It seems only logical that there would be a connection between
blood flow through the adrenal and the steroid output of the gland. This seems to be regulated
to some extent in a paracrine fashion by the vascular endothelium.
2.2.4 Intra-adrenal CRH/ACTH system
CRR, as described before, is a key hypophysiotrophic hormone regulating adrenocortical
activity through the activity of the HPA-axis. However, CRR is not only produced by the
hypothalamus, and is found in the adrenal gland itself, where it has direct effects on adrenal
activity. Although ACTH is derived from the anterior pituitary, it is also produced by the
adrenal. There is thus an intra-adrenal CRR/ ACTH system involved in regulating
adrenocortical activity.
Bomstein et al. found evidence for a direct effect, i.e. not through pituitary activation, of
CRR on adrenocortical cells. He showed that atrophy of the cortex in hypophysectomized rats
could be reduced by CRR [58]. CRR also enhances adrenal responsiveness to ACTH. Ovine
CRR was found to stimulate cortisol release in man independent of ACTH [59]. This effect of
CRR seems not to be without mediation from other factors, either a synergistic effect with
ACTH or some intermediary factor released from the medulla exist.
Intra-adrenal ACTH is also produced by the medulla [60]. This ACTH seems to be
released from the medulla in response to CRR stimulation. Similarly to the central
CRR/ ACTH system the intra-adrenal CRR/ ACTH system is also regulated by feedback
mechanisms. Furthermore, the activity of the intra-adrenal CRR/ ACTH system is greatly
increased in hypophysectomized animals. The intra-adrenal CRR/ACTH system is believed to
be of great importance in adrenocortical function.
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2.3 Mechanism of ACTH action
Binding of ACTH to its receptor in the zona fasciculata leads to the activation of
steroidogenesis and the release of cortisol. ACTH binds to a transmembrane G-coupled
protein receptor [4]. These transmembrane hormone receptors are associated with G proteins
on the inside of the cellular membrane. Most G proteins are heterotrimers consisting of a, ~
and y subunits. If the receptor protein is unoccupied, the G protein a subunit is associated
with GDP. Activation of the receptor by hormone results in displacement of GDP by GTP in
the a subunit. This in turn leads to the dissociation of the a subunit, which then associates
with adenyl ate cyclase (also bound to the inner cell membrane). The a subunit then stimulates
adenyl ate cyclase to produce cAMP from ATP. The a subunit has intrinsic GTPase activity
and once the GTP is hydrolyzed to GDP, the a subunit reallocates to the ~ and y subunits.
This activation cycle will continue while the G-coupled protein receptor is occupied by
hormone. Fig. 2.5 demonstrates the cycle. cAMP produced by adenyl ate cyclase is an intra
cellular second messenger molecule that can induce changes in various metabolic pathways.
This is achieved by cAMP binding to the two regulatory subunits of cAMP-dependent protein
kinase, which causes the release of two catalytic subunits. The catalytic subunits can
phosphorylate a number of enzymes on specific serine and threonine residues, bringing about
changes in their catalytic activity. In the steroidogenic cells of the zona fasciculata cAMP
induces: 1) increased rates of cholesterol ester hydrolysis to free cholesterol, 2) increased
transport of free cholesterol into the mitochondria and 3) stimulation of the cholesterol side
chain cleavage reaction in the mitochondria [61].
2.4 Biology of cortisol
2.4.1 Cortisol in circulation
It is evident from the above discussion that stimulation of the adrenal cortex by ACTH
leads to increased release of cortisol into the bloodstream from the adrenal. There is
equilibrium between free and protein-bound cortisol in circulation (fig. 2.6). Binding of
cortisol to plasma proteins increases its half-life. The bound fraction is mainly bound to
corticosteroid-binding globulin (CBG) and some is bound to albumin [12].
Stellenbosch University http://scholar.sun.ac.za
18
(d)
(b)
cAMP
cAMP
Figure 2.5. Graphic presentation of the ACTH receptor activation cycle. Box a shows ligand
binding to the transmembrane G-coupled receptor and box b shows the consequent
replacement of GDP with GTP. Boxes c and d show the activation of adenylate cyclase by the
GTP bound a subunit and the subsequent hydrolysis of GTP respectively. Reproduced from
[4].
The pool of free cortisol is the active concentration i.e. that which is able to cross the
membrane of target cells and bind to the receptor. This equilibrium between the bound and
free cortisol is influenced by various factors and has major physiological implications. CBG is
produced in the liver and its production is hormonally regulated [62]. Pregnancy is also
known to increase the levels of CBG. Certain illnesses, like nephrosis, cirrhosis and multiple
myeloma suppress CBG levels. When CBG levels rise, more cortisol becomes bound
resulting in a decrease of free cortisol. This alleviates the suppressing effect of
glucocorticoids on the release of ACTH from the pituitary. An increase in ACTH will lead to
a rise in cortisol and a new equilibrium is reached in which the bound cortisol is higher and
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the free cortisol is normal. Changes in the opposite direction also occur. Plasma total cortisol
concentrations are therefore not always indicative of glucocorticoid excess or deficiency.
ACTH
Adrenal
cortex
-----------. Free cortisol
in plasma
(~O,5 ug/dl)
Anterior
/.. pituitary---
Protein-bound
Cortisol in plasma
(13 ug/dl)
-----------. Tissue
cortisol
Figure 2.6. The interrelations of free and bound cortisol. The dashed arrow indicates that
cortisol inhibits ACTH secretion. The value for free cortisol is an approximation; in most
studies, it is calculated by subtracting the protein-bound cortisol from the total plasma
cortisol. Reproduced from [12].
2.4.2 Cortisol catabolism
The liver is the principal site for glucocorticoid catabolism [63,64]. Most cortisol is
reduced to dihydrocortisol and then to tetrahydrocortisol. Glucuronyl transferase catalyzes the
conjugation of the reduced cortisol to glucuronic acid. Some cortisol is converted to 17-
keto steroids and some, by 11~-hydroxysteroid dehydrogenase (11~-HSD), to cortisone, which
is also conjugated to glucuronic acid. Glucuronide conjugates of cortisol are freely soluble
and are excreted in the urine. The 17-ketosteroids are conjugated to sulfate and also excreted
in the urine. Some 15% of the secreted cortisol is excreted in the stool via the enterohepatic
circulation. Liver disease can result in a lowered capacity to catabolize cortisol. Certain
stresses like surgery in humans have the same effect. This can lead to an increase of free
plasma cortisol concentration to levels higher than those attained with maximal ACTH
stimulation without stress. Physiological stress can thus influence cortisol levels by means
other than activation of the HPA-axis.
Stellenbosch University http://scholar.sun.ac.za
20
2.4.3 Cortisol mechanism of action
Glucocorticoids, and all the other cortical steroid hormones, are derivatives of cholesterol
[4]. They all contain the cyclopentanoperhydrophenanthrene steroid nucleus (fig. 3.1).
Cortisol is an amphipathic compound and crosses the plasma membrane of target cells easily.
The glucocorticoid receptor (GR) is found in the cytoplasm of cortisol target cells. Human
GR was cloned in 1985. It is a 777 amino acid protein, also a member of the superfamily of
ligand regulated nuclear receptors [65]. The specific functions of GR are localized in so-
called domains. They are the ligand binding domain (LBD), DNA binding domain (DBD) and
two activation domains [66,67]. In the absence of steroid, GR is associated with two hsp90
molecules and other proteins in a multi-protein complex. Upon binding of steroid, GR
undergoes a conformational change, dissociates from the complex and translocates across the
nuclear membrane.
In the nucleus, GR binds to target DNA sequences termed glucocorticoid response
elements (GREs) [68]. This results in activation or increased transcription of the target gene
and is called transactivation. Repression of transcription is also possible for certain target
genes through transrepression. In this case the DNA target sequence is called a negative GRE
(nGRE). The ACTH precursor gene, pro-opiomelanocortin (POMC), has a nGRE that binds
multirners of GR [69]. This transrepression of GR is responsible for the negative feedback
inhibition of glucocorticoids on ACTH production in the HPA-axis.
2.5 Cortisol and carbohydrate metabolism
2.5.1 Regulation of body heat
Control of body heat in homeothermic organisms is an extremely complicated process. If
the organism produces no heat, it will soon reach the temperature of the environment through
simple thermal equilibration. Most non-hibernating mammals have optimum core
temperatures that are maintained through reflex coordination at a very precise temperature
irrespective ofthat of the environment. This temperature is more or less 37°C.
There are a number of processes that produce body heat. Most involve biochemical
reactions and the metabolic rate thus has a large influence on body heat. The activity of
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skeletal muscle contributes greatly to body heat production. Fever is the result of heat
production caused by immune responses and will not be discussed here. Heat is mostly lost
through radiation and convection from the body and also through excretion of urine and stool.
Ambient conditions mostly determine the rate of heat loss by radiation and convection. If an
organism is exposed to extreme cold, the basal metabolic rate (BMR) is not sufficient to
produce adequate heat. In such conditions shivering is an important means of body heat
production. Shivering is an involuntarily action of skeletal muscle induced by central neural
reflexes [70,71]. Shivering is a series of intense random contractions of skeletal muscle and
requires a large amount of energy. Glucose is a key energy source for this method of body
heat production.
Exposure to extremely cold weather conditions for long periods of time requires sufficient
mobilization of glucose to maintain blood glucose at physiologically favorable
concentrations. The main source of glucose in the post absorptive phase is stored glycogen. In
a man of average build, the liver stores glycogen to a maximum of 6% of its mass (100 g),
and skeletal muscle to 3% of its mass (400 g).
Depletion of the glycogen stores leads to the activation of various gluconeogenic enzymes.
This activation is orchestrated by an integrated hormonal response including glucagon [72],
epinephrine, norepinephrine [73] and cortisol [74,75]. Under normal conditions the effects of
glucocorticoids on carbohydrate metabolism do not seem vital to sustaining life. However,
when an organism is on the verge of hypothermia, which can lead to death, the contribution of
glucocorticoids to maintaining adequate blood glucose concentrations is indispensable. In an
organism like the Angora goat, in which the cortisol response to stress is severely impaired
[3], prolonged exposure to extreme cold could be fatal.
2.5.2 Liver glycogen as blood glucose source
Regulation of glycogen stores in the liver is under control of numerous effectors. Many
enzymes are involved in both glycogenesis (biosynthesis of glycogen) and glycogenolysis
(breakdown of glycogen to glucose). GLUT-2 is a glucose transporter, which mediates the
facilitated diffusion of glucose across the hepatocyte membrane in both directions [76].
Insulin does not strongly regulate GLUT-2 and its transport capacity is not limiting for the
uptake or release of glucose. As a result the glucose concentrations in the blood and
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hepatocytes are the same. This allows the liver to act as a biosensor for blood glucose
concentrations.
Glycogenesis and glycogenolysis are complicated processes and the cellular machinery
involved appears to be subject to cellular compartmentalization [77]. During glycogenesis
glycogenin (associated with glycogen synthase) autocatalytically attaches the C-I carbon of
UDP-glucose to one of its tyrosine residues. This is the first step in the formation of a glucan
chain six to seven glucose residues long, attached by a-I,4-glucosidic bonds through
autocatalysis of glycogenin. Glycogen synthase then dissociates from glycogenin and further
polymerizes glucose to the glucan chain using UDP-glucose as substrate. Eventually
branching enzyme transfers a terminal oligo-glucan (at least six glucose units) to a
neighboring glucan chain. The liberated C-I carbon of the oligo-glucan is attached to the C-6
carbon of a glucose unit in the neighbouring chain.
A mature glycogen molecule takes on the shape of a branched structure called a p-particle
and consists of roughly 60 000 glucose units. Up to 40 p-particles can complex to form so-
called a-rosettes.
The breakdown of glycogen (glycogenolysis) starts with the liberation of terminal glucose
units through the hydrolysis of glycogen phosphorylase. This reaction requires Pj and releases
glucose-I-phosphate from glycogen. When the external glucan chains are no longer than four
glucose units, the transferase activity of debranching enzyme removes a maltotriose unit from
the a-I,6-linked stub. The maltotriose unit is then attached to the C-4 carbon of the main
chain through an ce-I,4-glucosidic bond. The single remaining a-I,6-attached glucose is then
removed by the ce-I,6-glucosidase activity of debranching enzyme and liberated as D-glucose.
Glycogen phosphorylase continues to breakdown the glycogen until only the last glucose
remains attached to glycogenin. The debranching enzyme can then hydrolyse the final bond,
freeing the last glucose from glycogenin. Fig. 2.7 graphically shows the biosynthesis and
breakdown of glycogen.
2.5.3 The role of cortisol in maintaining sufficient blood glucose concentrations
Although many different effectors are involved, glycogenesis and glycogenolysis are
mainly controlled by the phosphorylation status of glycogen synthase and glycogen
phosphorylase, respectively [78,79]. Both enzymes exist in an active a, and an inactive b
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form. Glycogen synthase is controlled by the reversible phosphorylation of multiple serine
residues near the Nand etermini [80]. Phosphorylation of the enzyme leads to inactivation
through a decreased Vmax. Numerous protein kinases target glycogen synthase. However,
glucose and glucagon are the main effectors initiating the dephosphorylation and
phosphorylation of the synthase, respectively [81].
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Figure 2.7. Schematic presentation of glycogen biosynthesis (glycogenesis) and breakdown
(glycogenolysis), with the main enzymes involved indicated. Reproduced from [77].
The ability of liver glycogen phosphorylase to produce glucose-I-phosphate from
glycogen is dependent on intact phosphorylase kinase a [82]. This kinase produces the active
glycogen phosphorylase a from the inactive b form by phosphorylating Ser'", Furthermore,
both glycogen synthase and phosphorylase are under the control of protein phosphatase-l G
(PP-lG) [83]. PP-lG dephosphorylates the enzymes and thus produces an active synthase and
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an inactive phosphorylase, and in so doing promotes glycogen biosynthesis. There are many
glycogenic and glycogenolytic agents. The intricacies of how they induce changes in the
intra-cellular pathways controlling glycogen stores will not be discussed here. However, the
main glycogenic agents are: glucose, insulin, glycogenic amino acids, fructose and
glucocorticoids. Conversely the main glycogenolytic agents are: glucagon, epinephrine,
splanchnic nerve activity and eicosanoids.
The focus here is on how glucocorticoids contribute to ensuring adequate blood glucose
levels during periods of high glucose demand from skeletal muscle. This is achieved by
glucocorticoids acting as glycogenic agents, ensuring that sufficient glycogen stores are
maintained. Glucocorticoid administration in vivo results in activation of glycogen synthase
and inactivation of phosphorylase [84]. However, glucocorticoids are necessary for glucagon
to exert its gluconeogenic effect during periods of fasting [75]. Release of glucose (produced
from gluconeogenesis) from the liver is further enhanced by glucocorticoids increasing
hepatic glucose-6-phosphatase activity.
Glucocorticoids have far-reaching effects on intermediary metabolism. These include a
restraint on the hypoglycemic effect of insulin [85] and also increased peripheral protein
catabolism together with an increased hepatic uptake of amino acids to serve as
gluconeogenic substrate [12]. Engelbrecht et al. have shown intravenous injection of insulin
to cause a marked increase in blood cortisol levels in the Boer goat and Merino sheep [3].
Comparatively the Angora goat showed an impaired cortisol response to the drop in blood
glucose. This impaired cortisol response is believed to be responsible for the Angora goat's
inability to maintain adequate blood glucose levels during exposure to extreme wet, windy
and cold weather. The inability to produce sufficient body heat finally leads to hypothermia,
and death soon follows.
The concerted effects of glucocorticoids on carbohydrate metabolism are to maintain blood
glucose levels at physiologically favourable levels. These effects become even more
pronounced under extremely stressful conditions when there is considerable HPA-axis
activity.
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2.6 Conclusion
Neuro-endocrine mediation is central to the stress response in most animals and man. The
functions of the HPA-axis as a regulatory unit in this response are vital in orchestrating a
proper response to noxious stimuli. In the Angora goat a malfunction in the neuro-endocrine
mediated response to cold stress results in an abrupt drop in blood glucose concentration. It is
the function of cortisol, together with numerous other factors, to promote a rise in blood
glucose during a hypoglycemic episode. The adrenal cortex of the Angora goat fails to
produce adequate amounts of cortisol due to insufficient neuro-endocrine mediation of the
stress response. Finally the Angora goat suffers from critical hypoglycemia when exposed to
extreme cold and this results in central collapse and death.
Adrenal steroidogenesis is central to cortisol biosynthesis. Various enzymes and co-factors
are responsible to maintain a proper flux balance through the steroidogenic pathways, which
ultimately produce a number of different hormones. Any defect in a steroidogenic enzyme or
mediating factor could result in severe impairment or likewise an overproduction of certain
steroid hormones. The next chapter focuses on the biochemistry of the adrenocortical
steroidogenic processes. Special attention is given to CYP17, an enzyme that influences the
balance between glucocorticoid and androgen production. Finally an overview is given of
previous research implicating CYP 17 in the hypoadrenocorticism of the Angora goat.
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CHAPTER3
ADRENAL STEROIDOGENESIS: KEY TO CORTISOL
BIOSYNTHESIS
3.1 Anatomy and morphology of the adrenal gland
Humans and most other mammals have two bilateral encapsulated adrenal glands. These
glands are situated around the superior poles of the kidneys [14]. Morphologically the adrenal
gland consists of medullary and cortical tissue. The medulla occupies the centre of the gland.
From an evolutionary point of view the medulla is a sympathetic ganglion in which the
postganglionic nerves lost their axons and became secretory endocrine cells. Medullary cells
are under the control of preganglionic nerve stimulation of the splanchnic nerve [86]. The
secretory cells of the medulla are organized in interlacing cords and are densely innervated by
splanchnic nerve fibres. Two main types of cells can be distinguished in the medulla, namely
the epinephrine secreting type with large less dense granules and the norepinephrine secreting
type with smaller, denser granules.
The adrenal cortex is made up of three distinct zones layered on top of one another. Each
zone has a unique contribution to the gland's steroidogenic output. These zones are from the
outer to inner layer, the zona glomerulosa, zonafasciculata and zona reticularis. The medulla
is completely surrounded by cortical tissue. Cortical tissue makes up 72% of the adrenal mass
[12]. Of this the zona fasciculata constitutes 50% and the zona glomerulosa and zona
reticularis 15% and 7% respectively. Adreno-medullary cells, like other cells of neural origin,
do not regenerate. However, zona glomerulosa cells in addition to their aldosterone secreting
function also produce new cortical cells. When the two inner zones of the cortex are removed,
a new zona fasciculata and zona reticularis develop from glomerular cells attached to the
capsule [87]. Fig. 3.1 shows a cross section of the adrenal gland.
Many small branches from the phrenic and renal arteries and the aorta supply the gland
with arterial blood. A subcapsular arteriolar plexus diverges into the cortex and also sends
blood to the sinusoids of the medulla. There are, however, a few arterioles passing directly
through the cortex to the medulla from the capsule. The vascular network of the adrenal gland
has evolved to accommodate a relatively large blood flow through the gland.
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Figure 3.1. Cross section through the human adrenal gland (Cap) - adrenal capsule, (AT) -
adipose tissue, (V) - vein. Reproduced from [14].
3.2 Hormones of the adrenal cortex
The adrenal cortex delivers steroid hormones into the general blood circulation from where
it is delivered to various target cells throughout the body. Their actions have a considerable
impact on sexual development and function, electrolyte balance, intermediary metabolism and
stress management. The steroid hormones of the adrenal cortex are derivatives of cholesterol
[4]. Similar to cholesterol, bile acids, vitamin D, ovarian steroids and testicular steroids, they
also contain a cyclopentanoperhydrophenanthrene nucleus (fig. 3.2).
Figure 3.2. The cyclopentanoperhydrophenanthrene steroid nucleus.
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Gonadal and adrenocortical steroids can be classified into three categories, C21, C 19 and
CI8 according to the number of carbon atoms in the molecule [12]. The C21 steroids have a
two-carbon side chain attached to carbon 17 of the steroid nucleus. C 19 steroids have either a
keto or hydroxyl group at this position. In addition to either the keto or hydroxyl group at
carbon 17, the CI8 steroids have no angular methyl group attached at carbon 100fthe steroid
nucleus.
Although these properties make for easy classification they are not solely responsible for the
physiological actions of the hormones. The C2I steroids are further classified as either
mineralocorticoids or glucocorticoids using Selye's terminology. However, all C21 steroids
have both mineralocorticoid and glucocorticoid activity, with one or the other activity
predominating. Table 3.1 lists a number of C21 steroids and their relative potencies as
mineralocorticoids and glucocorticoids.
Although innumerable steroids have been isolated from the adrenals of many different
animals, most are not secreted in physiologically significant amounts. Those that bear
physiological significance are: the mineralocorticoid aldosterone, the glucocorticoids cortisol
and corticosterone and the androgens dehydroepiandrosterone (DHEA) and androstenedione.
Furthermore, the adrenal is known to secrete small amounts of estrogen. However, most of
the circulating estrogen that is not of ovarian origin is formed in the circulation from adrenal
androstenedione. The major C2I steroids secreted by adrenocortical tissue of most animals are
aldosterone, corticosterone and cortisol. The ratio of the two glucocorticoids secreted,
however, differs among species. Normally one or the other would be the dominant
glucocorticoid of a specific species [2]. Birds, mice and rats secrete predominantly
corticosterone, whereas dogs secrete almost equal amounts of the two glucocorticoids.
Humans, monkeys, cats and sheep mainly secrete cortisol.
3.2.1 Adrenal androgens and estrogens
Androgens are those steroid hormones that bring about masculinity and also promote
protein anabolism and growth. However, the adrenal androgens DHEA and androstenedione
have less than 20% of the potency of testosterone, the main androgen secreted by the testis.
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Table 3.1. Relative potencies of C2l steroids compared with cortisol 1
Steroid Glucocorticoid Mineralocorticoid
activity activity
Cortisol 1.0 l.0
Corticosterone 0.3 IS
Aldosterone 0.3 3000
Deoxycorticosterone 0.2 100
Cortisone 0.7 l.0
Prednisolone 4 0.8
9a- FIuoro-cortiso I 10 125
Dexamethasone 25 -0
I Values are approximations based on liver glycogen deposition of anti-
inflammatory assays for glucocorticoid activity, and effect on urinary Na+/K+
or maintenance of adrenolectomyzed animals for mineralocorticoid activity.
The last three steroids listed are synthetic compounds that do not occur
naturally. Reproduced from [12].
Testicular androgen secretion is under the control of gonadotrophins from the pituitary, and is
regulated through the interplay of hormones acting in the hypothalamic-pituitary-gonadal axis
(HPG-axis). The HPG-axis functions in a similar fashion as the HPA-axis, but will not be
discussed here. ACTH, and thus the HPA-axis, regulates adrenal androgen secretion. In both
adult men and women DHEA plasma concentrations are 300 ug/dl. Adrenal androgens are
responsible for the development of secondary sex characteristics since they are not as potent
as testosterone. However, in certain conditions where their secretion is significantly increased,
they can cause severe phenotypic alterations. In prepubertal boys it causes precocious
pseudopuberty and in females pseudohermaphroditism and the adrenogenatil syndrome [8].
As mentioned earlier, the adrenal itself secretes very little estrogen. Androstenedione,
however, is aromatized to form estrogen and is an important source of estrogens in males and
postmenopausal woman [88].
3.2.2 Glucocorticoids
In the preVIOUSchapter the role of cortisol in carbohydrate metabolism and certain
elements of its biology were discussed in some detail. Here some important properties of
glucocorticoids in general will be mentioned. Basal concentrations of glucocorticoids are
important in the regulation of intermediary metabolism and help the organism to cope with
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various stress factors. Furthermore, immune function is also suppressed to some extent by
glucocorticoids and they are therefore important in preventing the onset of autoimmune
diseases [89]. Due to the anti-insulin effect of glucocorticoids in peripheral tissue (excluding
heart and brain) they worsen diabetes and can lead to fatal hypoglycemia in fasting
adrenalectomized individuals. The permissive effects of glucocorticoids are important for
other hormone activity to be optimal. The calorigenic effects of glucagon and the
catecholamines are dependent on the permissive effects of glucocorticoids [73,75] and so are
the lipolytic effect [90], pressor responses and bronchodilation effect of the catecholamines
[91]. The vasoconstrictive effect of norepinephrine is also dependent on glucocorticoid
support. Thus adrenal insufficiency further prevents vascular compensation for the
concomitant hypovolemia. Glucocorticoid insufficiency is further associated with the inability
to excrete a water load, which is only rectified by the administration of glucocorticoids [92].
Circulating eosinophil [93] and basophil [94] numbers are lowered by glucocorticoids, while
neutrophil [95], platelet [96] and red blood cell [97] counts are increased. Glucocorticoids
help an organism deal with a wide variety of stress factors. The word stress is, however, a
term used very loosely in modem times. In this context glucocorticoids promote actions that
counteract the manifestations brought about by noxious stimuli that cause an increase in
ACTH secretion.
3.2.3 Mineralocorticoids
Sodium concentration in the ECF is the mam target of mineralocorticoid action.
Mineralocorticoid action results in absorption of sodium from urine, sweat, saliva and gastric
juice. Sodium diffuses from these fluids into the neighbouring cells and is actively transported
from these cells into the interstitial fluid [98]. The mechanism of action of aldosterone
causing sodium retention in ECF is coupled to an exchange for potassium and hydrogen ions
producing potassium and hydrogen diuresis. The mechanism of action of aldosterone is
similar to that of cortisol discussed in the previous chapter.
Aldosterone action results in the biosynthesis of new proteins. However, data exist which
indicate that binding of aldosterone to the cellular membrane can also evoke
mineralocorticoid effects [99]. Both mechanisms though seem to bring about an increased
activity of the Na+/K+ ATPase transporters. It is interesting to note that in vivo the
mineralocorticoid receptor has a much higher affinity for glucocorticoids than the
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glucocorticoid receptor. Aldosterone sensitive tissues, however, have the enzyme 11~-HSD
[100]. This enzyme catalyzes the conversion of cortisol to cortisone and of corticosterone to
its 11-oxy derivative. Aldosterone, however, is not a substrate of 11~-HSD. This prevents the
glucocorticoids from having an appreciable mineralocorticoid effect. Adrenal insufficiency
causing inadequate aldosterone secretion results in excessive sodium and water loss. A low
sodium plasma concentration results in hypovolemia that could eventually result in
circulatory insufficiency and fatal shock if untreated. Mineralocorticoid excess first causes
potassium depletion due to prolonged potassium diuresis. Sodium is retained, but plasma
sodium concentrations remain normal since water is also retained with the osmotically active
sodium. Finally the ECF volume is significantly increased and high blood pressure results.
When the ECF volume reaches a certain threshold, sodium is excreted regardless of
aldosterone action on the renal tubules [101]. This is called the escape phenomenon. The
precise mechanism resulting in the sodium escape is not yet known.
3.3 Biochemistry of cortisol production
The intricacies of the biosynthesis of cortisol, the main glucocorticoid secreted by the
Angora goat adrenal will futher be focused on in this chapter. Cortisol biosynthesis occurs
primarily in the zonafasciculata and also the zona reticularis but not in the zona glomerulosa.
This is because the zona glomerulosa lacks CYP17, which is crucial for cortisol production.
The zona glomerulosa, however, is unique in expressing aldosterone synthase [102].
Therefore aldosterone is the only steroid with physiological significance that is secreted by
the zona glomerulosa. Later in this chapter, cortisol insufficiency in the Angora goat will be
discussed. As explained in Chapter 1, it is this lack of cortisol that is responsible for the
Angora goat's inability to withstand extreme environmental conditions.
Cholesterol is the precursor of all steroid hormones [4]. Acetate is the substrate for the de
novo synthesis of cholesterol. However, most cholesterol used for steroidogenesis is taken up
from low-density lipoproteins (LDL) in the circulation. Furthermore, ACTH upregulates LDL
receptor expression in adrenocortical cells [103]. In these cells cholesterol is esterified and
stored in lipid droplets. Cholesterol ester hydrolase (CEH), through the stimulation of ACTH,
liberates cholesterol from its esters [104]. Section 2.3 of the previous chapter described the
intracellular changes caused by ACTH. Cholesterol then is delivered to the mitochondria
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where it serves as substrate for steroid production. The intermediates of cortisol production
are shuttled between the mitochondria and the endoplasmic reticulum before the final reaction
catalyzed by cytochrome P450cll (CYPllBl) in the mitochondria yields cortisol. Fig. 3.3
shows the shuttling of cholesterol and other intermediates within the adrenocortical cell.
Protein
kinase A
11-Deoxy .. 17-0H
cortisol - Preg
SER
Figure 3.3. Graphic presentation of cholesterol delivery to the adrenocortical cell and
shuttling of steroid intermediates between the mitochondria and the endoplasmic reticulum.
(LDL) - low density lipoprotein, (CEH) - cholesterol ester hydrolase, (Pre g) - pregnenolone,
(SER) - smooth endoplasmic reticulum. Reproduced from [12].
3.3.1 Cholesterol delivery to the mitochondria
Free cholesterol has to be delivered to the inner mitochondrial membrane. Cytochrome
P450 side chain cleavage (CYPllA) is bound to the inner membrane and is the enzyme to
which cholesterol needs to be delivered. CYPIIA carries out the side chain cleavage reaction
on cholesterol and produces pregnenolone [105]. This reaction occurs in all steroidogenic
tissues regardless of the end product produced. Delivery of cholesterol to the inner
mitochondrial membrane does not occur by means of passive diffusion. It is rather the
specialized function of a short-lived mitochondrial import factor called the steroidogenic
acute regulatory protein (StAR). StAR is expressed in a wide variety of vertebrates ranging
from birds and fish to mammals [106].
The inhibition of StAR translation by the addition of a translation inhibitor (cycloheximide
(CHX), also inhibits the formation of CYPIIA-cholesterol complexes. This causes a dramatic
decrease in the steroidogenic flux. However, certain soluble hydroxycholesterol analogs, also
substrate to CYPI1A for steroid production, are able to maintain a high steroidogenic flux in
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the presence of CHX [107]. This is because these analogs are not constrained by membrane
barriers and therefore do not require StAR facilitated transport. StAR translation is induced by
heightened cAMP and protein kinase A levels which in tum are caused by ACTH receptor
activation [108]. Delivery of cholesterol to the mitochondria is thus under strict hormonal
control. It would therefore appear that the delivery of cholesterol to the inner mitochondrial
membrane, facilitated by StAR, has a high control coefficient in all steroidogenic pathways.
3.3.2 Enzymes involved in adrenal steroidogenesis
The family of cytochrome P450 enzymes is mainly involved in the control of adrenal
steroidogenesis but 3~-hydroxysteroid dehydrogenase (3~-HSD), not a cytochrome P450, also
plays a pivotal role in this process. The first reaction in steroidogenesis, as mentioned earlier,
is the conversion of cholesterol to pregnenolone by CYP11A. This is a three-step reaction
involving the successive hydroxylation of C22 and C20 followed by the cleavage of the
vicinal diol to yield pregnenolone and isocaproaldehyde [109]. The adrenal steroidogenic
enzymes are located either in the mitochondria or the endoplasmic reticulum. CYPI1A1 and
CYPIIBI are located in the mitochondrial inner membrane. 3~-HSD and the other two
cytochrome P450 enzymes, CYP17 and cytochrome P450c21 (CYP21) are located in the
endoplasmic reticulum.
Pregnenolone, produced in the mitochondria, moves to the endoplasmic reticulum where it
is either substrate to CYP17 or 3~-HSD. When substrate to CYPI7 it is hydroxylated at
carbon 17 to yield 17-hydroxy pregnenolone (170H-Preg), which is again substrate to
CYP17. 170H-Preg is then converted to DHEA through the lyase activity of CYP17.
Pregnenolone together with 170H-Preg and DHEA could also be substrate to 3~HSD. When
substrate to 3~-HSD the intermediates (in the ~5 isoforms) are dehydrogenated at the carbon
three position and converted to the ~4 isoforms. Pregnenolone, 170H-Preg and DHEA yield
progesterone, 17-hydroxy progesterone (170H-Prog) and androstenedione respectively after
conversion by 3~-HSD. Pregnenolone thus lies at the first junction in the steroidogenic
pathway. Progesterone and 170H-Prog (the ~4 isoforms) are substrate to CYP17.
Progesterone is hydroxylated to form 170H-Prog, and the CI7-C20 bond of 170H-Prog is
cleaved to form androstenedione. Progesterone and 170H-Prog could, however, also be
converted to deoxycorticosterone and deoxycortisol respectively by CYP21. These two
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intermediates then travel to the mitochondria where they are converted to corticosterone and
cortisol, respectively, by CYP11Bl. Fig. 3.4 shows a metabolic map of the steroidogenic
pathways in the zonafasciculata and zona reticularis.
3.3.3 Cytochrome P450 mode of action and properties
Cytochrome P450 is the collective name for hundreds of enzymes which have unique
spectral properties because they contain the protoporphyrin IX ring structure complexed with
iron [110,111]. The reduced vs. oxidized absorption difference spectrum shows a unique
maximum at 450 nm in the presence of carbon monoxide, hence the name P450. Detergent
treatment of P450 containing cellular vesicles does not destroy the cytochrome, but converts it
quantitatively to a solublized form with absorption maximum at 420 nm. This form of the
enzyme is inactive and is referred to as P420.
Fig. 3.5 shows a typical hydroxylation catalytic cycle for cytochrome P450 [112]. The
catalytic action of cytochrome P450 involves substrate binding and the subsequent uptake of
electrons, which enables the binding of oxygen to the complex. During the catalytic cycle of
cytochrome P450 the iron is subject to oxidation and reduction and exists in the ferric and
ferrous states. Once the ternary oxygen-enzyme-substrate complex takes up a second electron,
the molecular oxygen is split. The one oxygen atom is activated and the other is lost to water.
The activated oxygen atom becomes incorporated into the substrate to form a hydroxylated
product. The product is then released from the enzyme complex and the enzyme is
regenerated to its native substrate free ferric form.
The different cytochrome P450 enzymes involved III corticosteroid biosynthesis are
located in either the endoplasmic reticulum or the mitochondrial inner membrane, as
mentioned earlier. Depending on their localization there are differences in the electron
transfer mechanisms utilized during the hydroxylation reactions. In the mitochondria NADPH
reduces adrenodoxin reductase (ADXR), which in turn reduces adrenodoxin (ADX) [109].
Reduced ADX again reduces cytochrome P450 and shuttles between ADXR and cytochrome
P450. In the endoplasmic reticulum NADPH reduces NADPH-P450-reductase. The reductase
then transfers the electrons directly to cytochrome P450 [113].
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Figure 3.4. Schematic representation of adrenal steroidogenesis. Reproduced from [2].
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CYP17 is one of the most widely studied P450 cytochromes. This is mainly due to its dual
catalytic activity. This enzyme is responsible for the hydroxylation at C 17 of the C2I steroids,
and also for the C17, C20 lyase of the C17 hydroxylated steroids [114]. CYP17 is found in
the zona fasciculata and zona reticularis, but not in the zona glomerulosa. This is why the
zona glomerulosa does not produce corticosteroids but only the mineralocorticoid
aldosterone. However, the inner two cortical zones do produce both androgen (DHEA and
RH(Fe-O)3+
(RH)Fe2+(02)
(RH)Fe~2-)
Figure 3.5. Schematic presentation of the action of cytochrome P450 in hydroxylation
reactions. RH presents a substrate and ROH the corresponding product. Reproduced from
[112].
3.4 Dual activity of CYP17
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androstenedione) and glucocorticoid (170H-Preg and 170H-Prog) precursors. CYP17 lS
responsible for the production of all these precursors.
It has also been reported that human CYP 17 is responsible for both the 17 and 16a-
hydroxylation of progesterone [115]. This enzyme does not, however, produce any detectable
amounts of androstenedione from 170H-Prog. It is important to note that the conversion of
pregnenolone to DHEA by CYP17 (fig. 3.4) occurs with the release of the intermediate
170H-Preg from CYP17 [116]. In the steroidogenic Lydig cells of the testis pregnenolone is
mainly utilized for the production of androgens, while in the zona fasciculata and also the
zona reticularis, it is used for the production of glucocorticoids. CYP17 is expressed in the
ovary in the theca interna cells with very low expression in the granulosa cells of humans and
rats. Theca interna cells can therefore produce androgens, but the granulosa cells need
androgen precursors from the theca interna cells for estrogen production [117].
Differential regulation of the two activities of CYP 17 is responsible for this important shift
in steroid metabolism of different tissues. It has been proposed that electron flow to the
enzyme regulates the ratio of these two activities [118]. Furthermore, cytochrome bs (cyt bs)
has also been implicated in contributing to the altered 17a-hydroxylase and 17,20-lyase
activities [119-121]. However, the mechanism through which cyt bs modulates the dual
activity of CYP17 is far from fully elucidated. In the testis, high 17,20-lyase activity of
CYP17 is required for adequate amounts of androgen production. In human testes two
different cyt bs mRNA transcripts exist [122]. Both the cytochromes expressed were found to
augment the 17,20-lyase activity of CYP17 to a similar extent. A recent paper suggests that an
allosteric mechanism rather than simply electron flow plays an important role [123]. In this
study Lombard et al. showed that cyt bs exists in various multimeric configurations,
depending on the physiological conditions. The differential regulation of the 17a-
hydroxylation and 17,20-lyase activities of CYP17 is a complex phenomenon. It is, however,
known that different tissues have different steroidogenic requirements and that various
metabolic factors in these tissues influence the ratios of the two catalytic activities ofCYPI7.
Defects in CYP17 activity can manifest in total loss of activity, or so-called isolated 17,20-
lyase deficiency. In fully developed 17a-hydroxylase and 17,20-lyase deficiency, no sex
hormones are produced. This leads to the development of external female genitalia regardless
of genetic sex [124]. The pathway leading to corticosterone and aldosterone production is,
however, still intact. As a result elevated levels of l l-deoxycorticosterone and other
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mineralocorticoids persists. This causes hypertension and hypokalemia. The loss of cortisol is
compensated for by the glucocorticoid effect of the elevated corticosterone.
In isolated 17,20-lyase deficiency CYP17 still catalyzes the hydroxylation of the C21
steroids and sufficient cortisol is produced [125]. In this condition there is, however, still the
loss of sex hormone production.
It is evident that alterations of any of the enzymes involved in steroidogenesis can cause a
shift in the balance between the different steroid hormones produced. Such an alteration in the
steroid profile of an organism could have severe clinical or phenotypic manifestations. More
often than not, changes in the activities of the steroidogenic enzymes are the result of changes
in the gene structure of the enzymes. The next section will discuss some genetic alterations
(mutations) found in the CYP17 gene and their implications.
3.5 Mutations of the CYP17 gene
The nature of genetic mutations IS diverse. Genes can be completely deleted from
chromosomes, or large pieces of non-sense DNA can be inserted into the coding regions of
genes. Conversely, large parts of the coding regions of a gene can be deleted from the gene.
These insertion and deletion mutations often render the enzymes encoded by the genes
inactive. Likewise point mutations that disrupt the reading frame of a gene generally result in
a non-sense peptide being translated. However, point mutations that do not disrupt the reading
frame can also have severe effects on enzyme activity. Such mutations usually result in one
amino acid being substituted for another in an enzyme. Differences in enzyme activity from
such mutations are then attributable to that specific amino acid. The identification of single
amino acid substitution mutations in CVP genes has shed much light on the structure-function
relation of different regions of cytochrome P450.
In a human case study a single amino acid substitution (Phe93Cys) was reported to cause
CAH [126]. Hypertension is characteristic of this condition due to the overproduction of
mineralocorticoids other than aldosterone. With this mutation CYP17 retained only 10% of
both hydroxylation and lyase activities. Another study found that a serine to proline
substitution at amino acid position 106 also resulted in the complete abolishment of CVP 17
activity [127]. Both these mutations are found in a highly conserved region of CYP17. This
indicates that particular region is crucial for both hydroxylase and lyase activity.
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Co-expression of P450 reductase and CYP17 in COS-1 cells showed that an increase in the
ratio of reductase to CYP17 augmented the 17,20-lyase activity, but not the hydroxylase
activity [128]. Higher levels of the reductase are also able to increase the 17,20-lyase activity
of two constructed CYP17 mutants with either threonine or alanine at amino acid 106. This
indicates Sed 06 to be crucial to the conformation of the active site rather than facilitating in
the interaction with P450 reductase. Further site-directed mutagenesis studies have also,
however, shown amino acids beyond the active site to induce changes in the two activities of
the enzyme [129]. It is therefore important to understand the limitations in appointing
structure function properties to certain regions of CYP 17 based on kinetic differences induced
by single amino acid substitutions.
In humans, only two single amino acid substitution mutations have been identified that
cause isolated 17,20-lyase deficiency [130,131]. They are Arg347His and Arg358Gln. Both
these mutations alter the interaction of CYP17 with P450 reductase and cyt bs. Again this
points to the contribution the reducing partners have in the differential regulation of CYP17
activity.
Another region in CYP17 that seems to playa crucial role in the catalytic activity is the
proline rich domain (PRD) in the amino terminal of the enzyme. This region is believed to be
important in folding of the enzyme, and to prevent misfolding of the peptide prior to heme
binding [132]. In addition to the PRD in the amino terminal of CYP17, there are also two
other distinct sequence motifs. They are the signal-anchor sequence (SA) and the basic
sequence (BS) [133]. Unlike the PRD these two sequence motifs are not essential for correct
folding of the enzyme.
3.6 Previous research: CYP17 causes impaired cortisol biosynthesis in the
Angora goat
From the previous discussions it is clear that adrenocortical CYP17 activity plays an
extremely important role in shuttling of steroid intermediates between the androgen and
glucocorticoid production pathways. Alterations in either or both the hydroxylase and lyase
activities of the enzyme could severely affect the steroid output of the adrenal cortex. In
previous research from our laboratory Engelbrecht et al. found Angora goat adrenal
steroidogenesis to differ significantly from Boer goat and Merino sheep in terms of
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glucocorticoid and androgen output [7]. The conclusions drawn from that work were that
altered CYP17 activity in the Angora goat results in insufficient cortisol secretion from the
cortex in response to HPA-axis stimulation. This section will further summarize the key
findings of that study, which identified the primary site of the hypoadrenocorticism, and
ultimately Angora goat CYP17 as the enzyme responsible for the observed
hypoadrenocorticism in the Angora goat.
3.6.1 Identification of the primary site of the reduced adrenal function in the Angora goat
In a comparative study, Angora goats, Boer goats and Merino sheep were subjected to
intravenous injections of insulin, CRH and ACTH. Subsequently cortisol production was
measured in all three species (fig. 3.6).
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Figure 3.6. The effect of an intravenous injection of human insulin (0.1 IV/kg), on plasma
glucose and cortisol concentrations in the Angora goat, Boer goat and Merino sheep.
Reproduced from [2].
CRH and ACTH function in the HPA-axis was discussed in the previous chapter. Both these
compounds should elicit a cortisol response from the adrenal. Insulin, although indirectly,
should also facilitate the release of cortisol from the adrenal cortex. This is because insulin
induces a hypoglycemic condition that serves as a strong stress signal to the hypothalamus.
Cortisol released from the adrenal cortex then aids in rectifying the hypoglycemia as
discussed in Chapter 2. From fig. 3.6 it can be seen that the intravenous injection of human
insulin produced significant hypoglycemia in all three species. Insulin therefore successfully
induced artificial stress in the animals. Concomitantly there was an increase in plasma cortisol
levels with a peak at 90 minutes after injection in the Boer goat and Merino sheep. Although
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some fluctuation in cortisol levels was seen for the Angora goat, no real peak response was
observed. The impaired cortisol response to hypoglycemia supported the findings of Van
Rensburg (1971) [1] and Herselman (1990) [134] of the presence of hypoadrenocorticism in
high fibre producing Angora goats.
Furthermore, sheep CRH produced a peak cortisol response in the Merino sheep, but not in
the two goat species. This could be explained by the inability of sheep CRH to bind the goat
CRH receptor efficiently in the corticotrophes of the anterior pituitary. However, ACTH did
produce a definite rise in plasma cortisol levels in all three species. The response was
strongest in the Merino sheep and weakest in the Angora goat. These findings suggested that
the HPA-axis was functional in all three species. However, the Angora goat showed an
impaired cortisol response upon HPA-axis stimulation. The adrenal gland was therefore
identified as the primary site of the Angora goat's hypoadrenocorticism. Subsequently adrenal
steroidogenesis was investigated to find any anomalies that could explain the observed
hypoadrenocorticism in the Angora goat.
3.6.2 Implicating CYP 17 in the observed hypoadrenocorticism of the Angora goat
Angora goat adrenal steroidogenesis was again investigated in a comparative study with
the Boer goat and Merino sheep. Subcellular fractions (micro somes or mitochondria) were
used in the subsequent experiments determining various steroidogenic enzyme activities. The
relevant steroid intermediates and cofactors were added to the cellular preparations and the
steroids that were produced were analyzed. When pregnenolone was added as substrate the
glucocorticoid and androgen precursors formed were compared among the species (table 3.2).
Table 3.2 Comparative pregnenolone metabolism
Species %Glucocorticoidsteroid %DHEAand %A4 %Pregnenolone
precursors formed 170H-Preg formed remaining
(DOC & DOCL)1 formed
Angora goat 35.6 ± 8.9 34.7 ± 4.2 5.5 ± 2.33 1.06 ± 1.06
Boer goat 78.5 ± 13.9 8.8 ± 1.7 - 6.3 ± 4
Merino sheep 82.03 ± 6.5 0.0 ± 0.0 - -
'DOC: Deoxycorticosterone and DOCL: Deoxycortisol. Reproduced from [2].
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The Angora goat produced only 35% glucocorticoid precursors compared to the 78% and
82% of the Boer goat and Merino sheep respectively. Angora goat microsomes, however,
produced significantly more androgen precursors. Angora goat steroidogenic enzyme kinetic
and specificity differences result in a higher flux of steroid intermediates through the ~5
steroid pathway compared to the ~4 pathway (fig. 3.4). Similar experiments were done where
either only NADPH or NAD+, the respective cofactors for CYP17 and 3~-HSD, were added
to compare the activities of the two enzymes among the species tested. With pregnenolone
and NADPH added, the production of DHEA was measured to investigate CYP17 activity.
With pregnenolone and NAD+ added, the production of progesterone was measured to
investigate 3~HSD activity. Fig. 3.7 shows the formation of the relevant intermediates.
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Figure 3.7. Comparison of 3~-HSD and CYP17 activity in Angora goats, Boer goats and
Merino sheep. PROG: Progesterone, DHEA: Dehydroepiandrosterone. Reproduced from [2].
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The results indicated that 3~-HSD produced progesterone at similar rates in all three
species. DHEA production was, however, much faster in the Angora goat compared to the
other two species. Engelbrecht et al. found in this study that Angora goat CYP17 had a higher
affinity for pregnenolone than did Boer goat and Merino sheep CYP17 [7]. This resulted in an
over-production of androgen precursors at the cost of glucocorticoid precursors in the Angora
goat adrenal cortex. CYP17 activity was identified as an important contributing factor in the
Angora goat's hypoadrenocorticism. This work led to a new hypothesis regarding the cause of
the hypoadrenocorticism. The inbreeding practices over many years (Chapter 1) could have
preserved a mutation in the CYP 17 gene that caused the altered activity of CYP 17.
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3.6 Conclusion
CYP 17 was implicated in hypoadrenocorticism of the Angora goat. It is clear that the dual
catalytic activity of this steriodogenic enzyme plays a crucial role in shuttling of steroid
intermediates through the steroidogenic pathways. Ultimately CYP17 determines to a large
extent the ratio of glucocorticoid to androgen hormone production. It is the heightened
affinity of CYP 17 for the Ll5 steroid pathway in the Angora goat that results in an
overproduction of androgens at the cost of glucocorticoid production. This impaired
glucocorticoid biosynthesis forms the basis of the stress intolerant phenotype of the Angora
goat. CYP 17 thus remained the focus point in investigating hypoadrenocorticism in the
Angora goat.
The preference of the Angora goat adrenal CYP 17 for the Ll5pathway has not been shown
in other species to date. As the Angora goat CYP 17 gene was never before investigated on a
molecular level it was decided to synthesise the cDNA coding for the Angora goat CYP17.
The cloning and expression of this enzyme in a non-steroidogenic cell line, would enable us
to study the kinetics and enzymology of this hemoprotein in more detail. The following three
chapters describe the experimental work investigating the Angora goat CYPI7, and the
development of a genotype test capable of identifying different CYP 17 allelic combinations.
It is finally argued that different CYP 17 genotypes found in the Angora goat gene pool is at
least in part responsible for the observed hypoadrenocorticism in the Angora goat.
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CHAPTER4
SYNTHESIS OF FULL LENGTH ANGORA GOAT CYP 17 eDNA
4.1 Introduction
The aim of this study was to determine whether there is a genetic basis for the observed
hypoadrenocorticism in the Angora goat. It has been shown that the primary cause of the
Angora goat's hypoadrenocorticism is adrenocortical insufficiency [7]. This insufficiency
leads to inadequate cortisol release from the adrenal cortex upon stimulation by ACTH. The
inability to secrete sufficient cortisol in response to ACTH stimulation can have severe
implications. ACTH is released in response to CRB binding to its receptor on the
corticotrophe cells of the pituitary. CRB in turn is produced and released from the
hypothalamus as a result of a wide array of neuro stimuli innervating the hypothalamus. At
the level of the pituitary the neuro-endocrine connection is a complex entity, which plays a
vital role in maintaining homeostasis, enabling an organism to respond to changes in the
environment and to counteract them in a favourable fashion.
Various stress stimuli lead to an increase in the plasma ACTH concentration and the
subsequent actions of ACTH are responsible for a concomitant rise in the plasma cortisol
concentration. It is therefore clear that the inability of an organism to elevate its plasma
cortisol concentration through the interplay of neuro-endocrine signals could result in a stress-
intolerant phenotype.
Adrenal steroidogenesis has been studied extensively in the Angora goat, Boer goat and
Merino sheep [7]. Boer goats and Merino sheep do not generally show symptoms of stress
intolerance attributable to hypoadrenocorticism. Analysis of these studies revealed that
adrenal steroidogenesis in the Angora goat differed markedly from steroidogenesis in the
Boer goat and Merino sheep. The findings showed significant differences in CYP17 activity
in terms of pregnenolone and progesterone metabolism in these species.
CYP17 became the focus of further investigations into the Angora goat's
hypoadrenocorticism. Itwas hypothesized that a mutation in the gene encoding CYP17 could
be the cause of the differences observed in adrenal steroidogenesis between the above
mentioned livestock. Such a mutation could be the result of anyone of various mutations,
such as a frameshift, insertion, deletion, somatic or point mutation [135], and would most
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likely exist in the coding region of the gene. Mutations in the coding regions of genes are
propagated to the mRNA transcripts of the gene, which are present in the cells where the gene
is expressed. Furthermore, if a CYP 17 mutation existed in the Angora goat gene pool, it is
possible that a wild copy would also exist. Since it was reported by some breeders that their
breeding stocks still have goats that are not as susceptible to environmental stress as others
are, it was speculated that there were at least two alleles of the CYP17 gene in the Angora
goat gene pool. The CYP17 gene structure was therefore analyzed to compare the coding
region of the gene, i.e. the cDNA of the Angora goat to that of other related species.
4.2 RNA isolation and eDNA synthesis
4.2. J Introduction
The synthesis of cDNA, encoding a specific gene, requires isolation of intact mRNA from
the tissue expressing the gene of interest. CYP17 is expressed in the adrenal cortex. RNA
isolation is a sensitive procedure as RNA is extremely susceptible to endonucleolytic and
exonucleolytic attack from ribonucleases. In intact cells RNA is protected from endogenous
ribonucleases by means of cellular compartmentalization. Homogenization of tissue destroys
subcellular structures and these ribonucleases are brought into contact with the RNA. There
are various methods for inactivating ribonucleases. In this study, diethylpyrocarbonate
(DEPC), a strong inhibitor ofribonucleases [136], was used for this purpose. Various methods
exist for the isolation of RNA from tissue, for example: phenol-chloroform extraction and
centrifugation through a CsCI cushion. However, advanced technology in the field of
molecular biology today provides alternative methods for the preparation of high pure RNA
from tissue by employing anyone of a number of commercially available kits. These kits also
eliminate exposure of the researcher to harmful chemicals. A 260 nm/280 nm-absorbancy
ratio of 1.9 - 2.0 for a total RNA solution is considered to be RNA of high purity [137]. Using
an appropriate kit was the method of choice for RNA isolation in this study.
The cDNA of a gene bears all the information encoding the full length functional protein.
Sequence comparisons of cDNAs encoding specific proteins are thus a useful method for
comparing the primary structure of proteins from different species. Analysis of the cDNA
sequence of a gene can provide important information regarding the integrity of a protein
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expressed in a certain individual, or in a particular species, From such analysis and
comparisons it can be deduced whether a mutation might have occurred in a gene, severely
affecting the primary structure of a protein, or preventing the protein from being expressed.
This is conceivable when large regions of DNA have been removed (deletions) or inserted
(insertions) into the genomic copy of a gene, or when a premature stop codon has been
introduced in the DNA as a result of mutations. Single nucleotide mutations also occur which
lead to either the substitution of one amino acid for another, or disruption of the reading frame
resulting in a non-sense peptide being translated.
In a preparation of total RNA mRNA, which is present together with tRNA and rRNA, is
the minor constituent. Most mammalian mRNA transcripts are flanked with polyadenylic acid
residues at the 3' termini. This allows the purification of mRNA from total RNA with a kit
that employs small scale affinity binding of the mRNA to an immobilized functional group of
oligo(dT).
During a RT-PCR single stranded mRNA is used as template by a thermostable reverse
transcriptase in the presence of various co-factors. The reverse transcriptase synthesizes a
single strand DNA molecule complementary to and complexed with the mRNA molecule
primed with a specific primer complementary to a target sequence in the mRNA molecule.
The product is a double stranded mRNA-DNA hybrid molecule. In the subsequent stages,
after dissociation of the hybrid, the primers target the complementary sequences in the single
stranded DNA molecule and a thermal stable DNA polymerase amplifies the targeted DNA.
A negative control reaction should be included in any RT-PCR, in which all the reagents
except the reverse transcriptase are present. Amplification of DNA in this reaction is
indicative of DNA contamination.
4.2.2 Experimental procedure
RNA isolation
Adrenals were obtained from a four to five year old male goat immediately after
slaughtering the goat. The adrenals were subsequently flash frozen and stored in liquid
nitrogen. Total RNA was isolated using the High Pure™ RNA Tissue Kit from Roche
(Mannheim, Germany) according to the manufacturer's instructions. The surrounding
connective tissue was dissected from the gland. Adrenocortical tissue, 50 mg, was cut free
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from the gland and put in a glass/teflon homogenizing set containing buffer from the RNA
Tissue Kit. Homogenization was performed on ice and the homogenate used as starting
material for the isolation. The RNA was eluted in 200 ul water and stored at -80°C. RNA
concentration and purity was determined spectrophotometerically using a Beckman DU 650
spectrophotometer from Beckman (Palo Alto, CA 94304, USA).
Total RNA, 20 ul, was used as starting material for each mRNA immobilization
procedure, using the mRNA Capture Kit from Boehringer Manheim (Mannheim, Germany)
according to the manufacturer's instructions. The buffer was discarded once the mRNA
immobilization was completed.
cDNA synthesis
Complementary cDNA was synthesized by reverse transcription of mRNA using the
TitanrM One Tube RT-PCR system from Boehringer Manheim according to the manufacturer's
instructions. Two different RT-PCR amplifications were performed, one with total RNA and
one with mRNA as template.
Genetic homology of the Angora goat to sheep was assumed to be sufficient in the design
of primers used in the RT-PCR. The primers were designed complementary to target
sequences upstream and downstream of the ATG translational start and TGA translational
stop sites of sheep CYP17 (GENBANK accession number: L40335) respectively. All primers
used in this study were purchased from Integrated DNA Technologies, Inc. (Coralville, lA
52241, USA). Specifications of the primers are listed in appendix A. The reactions were set
up as follows: Three master mixes were prepared separately, I, II and III as shown in tables
4.1, 4.2 and 4.3 respectively.
(i) Template: mRNA
Master mix I was added to the tube, which contained the immobilized mRNA. Subsequently
master mix III was added to the same tube.
(ii) Template: total RNA
Master mix II was prepared in a normal PCR tube and master mix III was added to this tube
shortly afterwards.
The reaction mixtures were overlaid with a small drop of mineral oil purchased from Promega
(Madison, WI, USA). For amplification of mRNA, RT-PCR was performed in a PCR Sprint
thermocycler from Hybaid Ltd. (Ashford, Middlesex, UK) as follows: a reverse transcriptase
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step at 50 DCfor 30 min and an initial denaturation step at 94 DCfor 2 min, followed by 10
cycles of denaturation at 94 DCfor 30 s, annealing at 58 DCfor 30 s, and elongation at 68 DC
for 3 min. A further 25 cycles were performed adding 5 s to the elongation step for each
cycle, final elongation step at 68 DCfor 7 min, and further storage of the reactions at -20 De.
Table 4.1. RT-PCR master mix I
Reagents Vol. (J..lI) Final concentration
dH20 15.5
dNTPs 4 200 11M(Each)
GOOI (Left primer) 1 O.4I1M
G006 (Right primer) 1 O.4I1M
RNA template 0
DTT 2.5 5mM
RNase inhibitor 1 5U
TOTAL 25
Table 4.2. RT-PCR master mix II
Reagents Vol. (J..lI) Final concentration
dH20 5.5
dNTPs 4 200 11M(Each)
GOO1 (Left primer) 1 0.4 11M
G006 (Right primer) I 0.4 11M
RNA template 10
DTT 2.5 5mM
RNase inhibitor 1 5U
TOTAL 25
Table 4.3. RT-PCR master mix III
Reagents Vol. (J..lI)
dH20 14
5 X Buffer (Supplied) 10
RT-AMY 1
TOTAL 25
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LE agarose was purchased from Roche for agarose gel analysis of the RT-peR products.
DNA loading buffer (0.1% Orange G (w/v), 20% Ficoll (w/v), 10 mM EDTA, pH 7), 5 ul,
was added to 10 ul of each RT-peR mixture for electrophoresis. The samples were then
loaded on a 1% (w/v) agarose gel prepared in TAE buffer (40 mM Tris-acetate, 2 mM
Na2EDTA·2H20 and 20 mM acetic acid). Submerged electrophoresis was performed at 55 V
for 10 min and then at 110 V until the dye reached the end of the gel. Ethidium bromide was
purchased from Merck (Darmstadt) to stain gels in a 0.5 ug/rnl solution for 20 min. Stained
DNA fragments were then visualized on a UV transilluminator.
4.2.3 Results
RNA isolation
Spectrophotometeric analysis of the purified total RNA indicated that almost 4 ug of total
RNA was purified from 50 mg of adrenocortical tissue. The absorbance of a six times diluted
sample oftotal RNA at 260 nm and 280 nm was respectively 0.8267 and 0.4164. The 260/280
absorbency ratio was 1.9856.
cDNA synthesis
Two RT-peR amplifications were performed: (1) a one-step reaction with total RNA as
template, and (2) a one-step reaction with mRNA as template. Agarose gel analysis ofthe RT-
peR products revealed a distinct band of approximately 1.6 kb (fig. 4.1), which is of similar
size as sheep eYP17 cDNA (GENBANK accession number: L40335). Lane 5 (total RNA
template) shows a light degree of DNA smearing compared to lane 4 (mRNA template). This
could be as a result of non-specific DNA annealing. A negative control reaction was
performed to indicate contamination of the RT-peR with exogenous genomes, plasmids or
peR products, which amplified no fragment.
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Figure 4.1. One-step RT-PCR amplifications of Angora goat CYP17 mRNA transcripts. The
RT-PCR products (lOIlI) were analysed by 1% agarose gel electrophoresis followed by
ethidium bromide staining. Lane 1, negative control with total RNA as template; Lane 2,
negative control with mRNA as template; Lane 3, DNA molecular weight marker VI (Roche);
Lane 4, full length cDNA amplified in a one-step RT-PCR (mRNA template); Lane 5, full
length cDNA amplified in a one-step RT-PCR (total RNA template).
4.3 Amplification and sequencing of Angora goat CYP17
4.3. J Introduction
A RT-peR fragment of approximately 1.6 kb was produced in an attempt to amplify
Angora goat CYP 17. Sequence analysis of this fragment was essential to establish whether
the fragment was Angora goat CYP17 cDNA. Both strands of the cDNA had to be sequenced
to be certain every base assigned to every locus of the sequence was correct. Three sets of
primers were therefore used to sequence the sense and anti-sense strand of the RT-PCR
fragment. Once the sequence was known, comparative analyses using other known sequences
of CYP 17 cDNA from different species was possible.
4.3.2 Experimental procedure
Amplification of the RT-PCR product was necessary to obtain sufficient DNA for
sequencing. To further amplify the RT-PCR product it had to be purified from a preparative
agarose gel. DNA was purified from agarose gel slices using aPromega Wizard® PCR preps
DNA purification kit, according to the manufacturer's instructions. The gel purified RT-PCR
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product was used as template in a second round large scale (100 Ill) PCR. This PCR mixture
was loaded on a preparative agarose gel and the 1.6 kb DNA band was subsequently purified
for sequencing.
The RT-PCR product, 12 Ill, was mixed with DNA loading buffer in a 1:2.4 ratio and
loaded on a preparative 1% agarose gel. The gel consisted of NuSieve® GTG low melting
agarose purchased from Roche and normal LE agarose, also from Roche, mixed in a 1:3 ratio
respectively. After electrophoresis the gel was stained with ethidium bromide and the DNA
fragment corresponding to 1.6 kb was gel purified and eluted in water. Subsequently a second
round PCR amplification was performed using 10 III of the purified DNA as template in a
total volume of 100 Ill. Pwo DNA polymerase and dNTPs (mixture of dATP, dCTP, dGTP
and dTTP) were purchased from Roche. The reagents were added as shown in table 4.4 and
all reactions were overlaid with mineral oil (Promega) and amplified as follows: an initial
denaturation step at 94°C for 2 min, followed by 10 cycles of denaturation at 94°C for 30 s,
annealing at 58°C for 30 s, and elongation at 68°C for 3 min. A further 25 cycles were
performed adding 5 s to the elongation step for each cycle, final elongation step at 68°C for 7
min, and further storage of the reactions at -20 °C.
Table 4.4. PCR reagents added for the second round amplification ofthe RT-PCR product.
Reagents Vol. (Ill) Final concentration
dH20 66.5
lOX buffer (Supplied) 10
dNTPs 10 200 J.lM (Each)
GOOI (Left primer) 1.5 0.3 J.lM
G006 (Right primer) 1.5 0.3 J.lM
DNA template 10
Pwo polymerase 0.5 1.5 U
TOTAL 100
The PCR amplification was electrophoresised on a 1% preparative agarose gel and the DNA
fragment of approximately 1.6 kb was gel purified. The concentration of the purified DNA
was determined spectrophotometerically. Subsequently the purified DNA fragment was
sequenced using 13.3 ng/Ill of template DNA and 1.1 ng/Ill of primer DNA per sequencing
reaction. Specifications of the primers used are listed in appendix A. Nucleotide sequences
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were determined using the Bigdye™Version 2 diterminator sequencing kit (model373 A ABI,
Applied Biosystems, Foster City, CA) at the central analytical facility of the University of
Stellenbosch.
4.3.3 Results
The second round PCR amplification yielded approximately 3.5 ug DNA (93 ng/Ill).
Sequencing of this DNA produced six sequences, which were aligned with BioEdit (Hall T,
1999) to produce the complete cDNA sequence of the Angora goat CYP17 gene. The
sequence generated for the RT-PCR product in this study showed Angora goat CYP17 cDNA
to be 1 530 bp from the ATG translational start site to the TGA translational stop site.
Furthermore, four double nucleotide base pair peaks were detected at four random loci (base
pair 17, 122, 637 and 1 065) in the coding sequence on both the DNA sense and anti-sense
strands. Fig. 4.2 to fig. 4.5 show the double peaks generated by the sequencing for the DNA
sense and anti-sense strands. The complete sequence is shown in appendix B and is aligned
with goat CYP17 cDNA sequence to determine homology. The Angora goat (Capra
aegagrus) and Boer goat (Capra hircus) belong to the same genus and would therefore be
expected to share a high CYP17 cDNA homology. There are only four nucleotide differences
between Angora goat and Boer goat CYP17 cDNA and they are at the loci where the double
peaks are found in the Angora goat cDNA sequence.
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Figure 4.2. Graphic nucleotide sequence of Angora goat CYP 17 cDNA showing a double
nucleotide base peak at bp 17 in the cDNA. Graph A: nucleotide base at position 40
corresponds with nucleotide base 17 in the cDNA sequence. Graph B: nucleotide base at
position 376 corresponds with nucleotide base 17 in the cDNA sequence.
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Figure 4.3. Graphic nucleotide sequence of Angora goat CYP 17 cDNA showing a double
nucleotide base peak at bp 122 in the cDNA Graph A: nucleotide base at position 145
corresponds with nucleotide base 122 in the cDNA sequence. Graph B: nucleotide base at
position 271 corresponds with nucleotide base 122 in the cDNA sequence.
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Figure 4.4. Graphic nucleotide sequence of Angora goat CYP17 cDNA showing a double
nucleotide base peak at bp 637 in the cDNA. Graph A: nucleotide base at position 74
corresponds with nucleotide base 637 in the cDNA sequence. Graph B: nucleotide base at
position 337 corresponds with nucleotide base 637 in the cDNA sequence.
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Figure 4.5. Graphic nucleotide sequence of Angora goat CYP17 cDNA showing a double
nucleotide base peak at bp 1 065 in the cDNA. Graph A: nucleotide base at position 502
corresponds with nucleotide base 1 065 in the cDNA sequence. Graph B: nucleotide base at
position 515 corresponds with nucleotide base 1 065 in the cDNA sequence.
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4.4 Discussion
Total RNA isolated from Angora goat adrenocortical tissue yielded approximately 4 ug of
RNA. The one-step RT-PCR targeting Angora goat CYP17 produced a single DNA fragment
of approximately 1.6 kb using either total RNA or mRNA as template (fig. 4.1). The two
negative controls included in the RT-PCR produced no amplified fragments, indicating the
1.6 kb DNA fragment was derived from the RNA template. Furthermore, the size of the RT-
PCR product correlated well with other CYP17 cDNA transcripts in terms of size, which
strongly suggested the DNA fragment to be Angora goat CYP17 cDNA. However, only
sequence analysis could truly confirm the identity of the RT-PCR product. The RT-PCR
produced only one distinct amplified product indicating that the primers used did not anneal
to unspecific sequences in the RNA template. Judging from the agarose gel analysis of the
RT-PCR there is no considerable difference between the products of the different RNA
templates used. Using total RNA as template in a RT-PCR could eliminate a costly and time
consuming step in the preparation of cDNA.
The CYP17 cDNA sequence generated for the Angora goat (Capra aegagrus) (appendix
B) shares 99.74% homology with Boer goat (Capra hircus) CYP17 cDNA (GENBANK
accession number: AF251387). Only four nucleotide bases differed in the 1 530 bp coding
region of the two sequences. This ultimately confirmed the RT-PCR product produced in this
study to be Angora goat CYP17 cDNA. However, the sequencing results produced four
double peaks along the 1 530 bp coding region (fig. 4.2 - fig. 4.5). This could not simply be
regarded as sequencing anomalies, since these double peaks were detected in both the sense
and anti-sense strand of the cDNA. Furthermore, these double peaks were detected at the loci
where Angora goat and Boer goat CYP17 cDNA differed. This result therefore shows that
more than one copy of CYP17 cDNA was present in the sequencing sample differing by four
nucleotide bases at the indicated loci. These findings strongly indicate to the possibility that
the Angora goat, from which the RNA was isolated, expressed more than one CYP17 mRNA
copy in its adrenal cortex. Analysis of the cDNA reading frame, in terms of the genetic code,
indicated that three of the four nucleotide substitutions translated to amino acid substitutions
in the translated protein. The DNA base pair substitutions and their corresponding amino acid
substitutions were as follows: position 17, C/G - Ala/Gly; position 122, CIT - Pro/Leu;
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position 637, G/A - VallIle; position 1 065, G/A - no amino acid substitution (with positions
relating to the cDNA sequence).
Furthermore, the G/A substitution at position 637 caused an alteration in the Acs I
endonuclease recognition sequence. This substitution caused a change in the six base pair
recognition sequence of Acs I from 'AAATTC' to 'AAGTTC'. The latter sequence is not a
substrate for endonuclease cleavage by Acs I.
Adrenal steroidogenesis is a complex biochemical process through which various steroid
hormones are produced. These hormones are essential to maintaining homeostasis. Although
cortisol is not as vital for sustaining life, since life can be sustained for longer in the absence
of cortisol than aldosterone, it plays a very important role in stress management (Chapter 2).
A number of adrenal enzymes are responsible for the biosynthesis of cortisol from its
precursor, cholesterol. CYPI7 is a microsomal P450 essential to cortisol production. This
enzyme is one of the most widely studied cytochrome P450s due to its dual catalytic activity
[138]. CYP17 catalyses the hydroxylation and cleavage of C2l steroids and 17-
hydroxycorticoids respectively. Furthermore, this enzyme influences the ratio of androgen to
corticosteroid production due to its activity in both the ~5 and ~4 steroid pathways. The ~5
and ~4 pathways lead to androgen and corticosteroid production respectively. It should be
clear that any alteration in CYPI7 activity could influence the balance of adrenal steroid
hormone production.
Comparative studies investigating Angora goat, Boer goat and Merino sheep adrenal
steroidogenesis confirmed that Angora goat adrenals favoured the production of androgens to
that of the corticosteroids, compared to the two other species [7]. This seems to be the main
underlying mechanism for the hypoadrenocorticism observed in the Angora goat.
Furthermore, Angora goat CYPI7 channels much more pregnenolone through the ~5 steroid
pathway compared to Boer goat and Merino sheep. Interestingly Angora goat CYPI7 seems
to channel the same amount of progesterone through the ~4 steroid pathway as the other two
species. Comparison of the other steroid producing enzymes, including CYPIIA1, 3p-HSD,
CYP21 and CVP 11Blshowed no significant differences compared to Boer goat and Merino
sheep.
Analysis of the Angora goat CYP17 cDNA sequence suggested the likelihood of an
Angora goat from the Swartland farming district carrying two CYP17 copies. Since mRNA is
transcribed from genomic DNA it implies that the two alleged copies of the gene would be
inherently passed on to progeny in Mendelian fashion. Therefore the two genes would be
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distributed throughout the gene pool. It can only be speculated when a second copy of the
CVP 17 gene was introduced into the gene pool, if indeed it existed. It is, however, known that
inbreeding among Angora goats was common practice in the Angora goat industry [2]. This
was part of ongoing attempts to produce fleece with improved quality. Concomitant with
selecting for better quality fleece, was the rise in the stress intolerant phenotype among
Angora goats. It remains to be seen whether these two physical traits can be separated through
a breeding strategy.
In light of the possible existence of two Angora goat CYP 17 alleles, three possible CYP 17
genotypes could exist, namely two homozygote genotypes and one heterozygote genotype.
CYP 17 activity plays a delicate role in steroidogenic homeostasis. The possibility of three
different Angora goat CYP17 genotypes existing could have severe effects on the animal's
steroid hormone production. It seems likely that the Angora goat's hypoadrenocorticism could
be attributable to the existence of three CYP 17 genotypes. From the preceding discussion it is
conceivable that one, or possibly two, of the three proposed genotypes could be responsible
for the high incidence of stress intolerance in Angora goat farming stocks. However, the
Angora goat from which the eDNA was synthesized was described as hardened by the farmer.
It is therefore possible that the heterozygote CYP17 genotype does not exhibit a stress
intolerant phenotype. It was now vital to devise a test that could conclusively confirm the
existence of a CYP 17 polymorphism in Angora goats, and that could identify different
CYP 17 genotypes.
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CHAPTER5
DEVELOPMENT OF A PCR BASED RESTRICTION ENZYME
DIGEST TEST FOR CYP17 GENOTYPING
5.1 Introduction
The generation of two different Angora goat CYP17 cDNA sequences was a noteworthy
finding. Many different CYP17 mutations have been investigated in the past in other animals.
These mutations often result in single amino acid substitutions, which are generally caused by
point mutations. Studying the effects these individual amino acid changes have on CYP17
activity contributes to our knowledge of the structure function relationship of the enzyme
[131,133]. Such studies have also contributed to our understanding of the differential
regulation of the 17a-hydroxylase and 17,20-lyase activity of the enzyme. Considerable
contributions were made by those specific mutations that cause so-called isolated 17,20-lyase
deficiency.
The majority of these mutations were discovered because their effects on steroidogenesis
presented as clinically diagnosable endocrine abnormalities. Complete abolition of CYP 17
activity causes overproduction of mineralocorticoids and the inability to synthesize
glucocorticoid and sex hormones [139]. Absence of CYP17 lyase activity alone will result in
the failure to produce sex hormones.
Sequence analysis of the Angora goat CYP17 cDNA showed the presence of two non-
identical sequences. The two 1 530 bp sequences differed only by four nucleotide bases.
Whether all four of the substituted bases represent true mutations can not be told from cDNA
sequence analysis alone. It is though possible that through evolution a second copy of the
CYP17 gene evolved from a multi-mutation event that occurred over time. If a mutated
CYP 17 copy was responsible for the development of the stress intolerant phenotype among
Angora goats, natural selection would most likely have expelled the mutation from the gene
pool under normal circumstances. However, inbreeding practices that occurred may have
preserved such a mutation.
Restriction enzyme profiles were generated for the two different CYP 17 sequences,
which differed only by a single Acs I recognition sequence. One of the alleles has an Acs I
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recognition sequence at cDNA bp 635, which is lost in the second allele by a substitution of
adenine for guanine in the Acs I recognition sequence. The altered restriction endonuclease
profile between the two CYP17 cDNA sequences provided the basis for the development of a
CVP 17 genotype test. Development of a CVP 17 genotype test would allow Angora goats to
be tested, using genomic DNA, in order to determine their CYP17 genotype. Since the
Angora goat described in the previous chapter produced two different CYP17 cDNA
sequences the genotype test was developed using genomic DNA from that goat. This was
done so that the test could be validated by producing the expected result for a CVP 17
heterozygote Angora goat.
5.2 Isolation and sequencing of Angora goat genomic CYP17
5.2.1 Introduction
Genomic transcripts of many eukaryotic genes are larger than their corresponding mRNA
transcripts, because they possess the intron nucleotide sequences. Each living cell of a multi-
cellular organism has a nucleus in which genomic DNA is found. In diploid organisms each
cell nucleus has two copies of each gene, one from each parent. The intron nucleotide
sequences have many functions aiding in the processing of the primary transcript into mRNA
upon transcription of a gene. These sequences, however, are also useful in population studies.
Comparisons of the genomic nucleotide sequences of the two CVP 17 alleles identified in this
study in the Angora goat could therefore aid in determining the origins of the two genes.
Sequence analysis of the genomic copy of Angora goat CVP 17 was also necessary to aid in
the development of a CYP17 genotype test, since genomic DNA would be used in the test.
Genomic DNA was obtained from the same goat from which the adrenal glands were taken
(Chapter 4).
5.2.2 Experimental procedure
Blood was collected from the slaughtered goat directly into EDTA-coated tubes to prevent
clotting and DNA degradation and stored at 4°C. A Wizard® Genomic DNA Purification Kit
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was purchased from Promega and DNA was isolated from the blood samples according to the
manufacturer's instructions. After isolation the DNA pellet was rehydrated in water.
Three pairs of PCR primers were designed, complementary to sheep cDNA sequences,
aimed at producing three overlapping PCR fragments spanning the full length Angora goat
genomic CYP17 gene. Pwo DNA polymerase and dNTPs were purchased from Roche. The
PCR reagents were added as shown in table 5.1. All reactions were overlaid with mineral oil
(Promega) and amplified as follows: an initial denaturation step at 96 DCfor 2 min, followed
by 30 cycles of denaturation at 96 DCfor 1 min, annealing at 55 DCfor 75 s, and elongation at
72 DCfor 3 min, final elongation step at 72 DCfor 10min, and further storage of the reactions
at-20 DC.
Table 5.1. PCR amplification reagents with primers targeting Angora goat genomic CYPI7.
Reagents Vol. (~l) Final concentration
dH20 72.5
lOX Buffer (Supplied) 10
dNTPs 10 200 J.lM(Each)
*Left primer 1.5 300 nM
*Right primer 1.5 300nM
DNA template 4.0
Pwo 0.5 2.5 U
TOTAL 100
*Three primer pairs were used in three separate reactions. Appendix A
shows the primer specifications.
The PCR amplifications, 10 ul, were loaded on a 1% agarose gel for electrophoresis (fig.
5.1) and the remaining 90 ul of each reaction was loaded on a separate 1% preparative
agarose gel for electrophoresis. The DNA fragments of interest were gel purified with an
Agarose Gel DNA Extraction Kit from Roche according to the manufacturer's instructions.
The purified DNA fragments were sequenced as described in section 4.3.2 using 13.3 ng/ul of
template DNA and 1.1 ng/ul of primer DNA per sequencing reaction. Specifications of the
primers used are listed in appendix A.
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5.2.3 Results
Only two of the three peR amplifications targeting different segments of the genomic
eYPI7 gene produced fragments that were suitable for sequencing. Fig. 5.1 shows the DNA
fragments amplified by the three sets of primers. A very faint band is seen in lane 5 at
approximately 2.5 kb. The primers used for this amplification targeted the 5' terminal
segment of the gene and failed to produce a proper sequence. Lanes 3 and 4 show the
fragments produced by the primer pairs aimed at the 3' terminal segment and middle segment
of the gene respectively.
2500 bp
2000 bp
1 500 bp
Figure 5.1. Pï.R amplifications of different segments of Angora goat genomic eYPI7.
Amplification mixtures (10 ul) were analysed by 1% agarose gel electrophoresis followed by
ethidium bromide staining. Lane 1, negative control reaction; Lanes 2 and 6, 1 kb DNA
Ladder (Promega); Lane 3, primers targeting 3' terminal segment of gene; Lane 4, primers
targeting middle segment of gene; Lane 5, primers targeting 5' terminal segment of gene.
Sequencing of these two fragments showed them to overlap and include the TGA translational
stop site. The two segments were not completely sequenced on both sense and anti-sense
strands and therefore some bases assigned could be incorrect. The sequences generated for
Angora goat genomic eYPI7 were aligned with BioEdit (Hall T, 1999). This partial genomic
sequence was aligned with the Angora goat eYPI7 cDNA sequence (appendix e), which
allowed the determination of Angora goat eYPI7 exon and intron sizes as shown in table 5.2.
Since genomic C'Yl' 17 sequences were not available for sheep or Boer goat, comparisons
were made with human and baboon eYPI7 genomic sequences to draw an estimated genomic
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CYP17 gene map (fig. 5.2). Table 5.2 shows all the intron and exon sizes for human and
baboon CYP 17 and those available for the Angora goat.
Table 5.2. Genomic CYP17 intron and exon sizes (indicated by nucleotide base pair length)
compared for human, baboon and Angora goat. Human and baboon sizes obtained from [141].
Human Baboon Angora
Exon 1 297 297 /
IntronA 1668 1757 /
Exon2 143 143 /
IntronB 229 235 /
Exon 3 230 230 /
IntronC 662 641 /
Exon4 87 87 /
IntronD 694 1012 /
Exon5 216 216 216
IntronE 232 313 314
Exon6 170 170 170
IntronF 897 894 533
Exon7 104 104 104
IntronG 518 520 524
Exon8 284 284 287
/Not available
Bp 122 C(pro )1T(Leu) Bp 1 065 G/A No Substitution
!ntD IntE !ntF !ntG
Bp 17 C(Ala )/G(Gly) Bp 637 G(Val )/A(De)
Acs I Recognition sequence: AAATTC
Figure 5.2. A graphic presentation of the Angora goat genomic CYP 17 gene showing eight
exons (yellow) and seven introns (A to G). This gene map is an estimate, since the Angora
goat genomic CYP17 has not been sequenced completely. Similarity to Human and Baboon
genomic CYP 17 was assumed. The four nucleotide substitutions and their respective amino
acid substitutions are shown (numbers according to the 1530 bp eDNA sequence). The Acs I
recognition sequence is indicated, with the substituted base in red.
Stellenbosch University http://scholar.sun.ac.za
65
5.3 Development of a CYP17 genotype test
5.3.1 Introduction
The complete cDNA and partial genomic sequences for Angora goat CYP17 obtained in
this study provided sufficient information to devise a strategy for developing a CYP 17
genotype test. The nucleotide base substitution in exon 3 (fig. 5.2) of Angora goat CYP17
resulted in the alteration of the recognition sequence of the endonuclease Acs I. The altered
restriction profile of the two CYP 17 genes formed the basis of the genotype test developed in
this study. A strategy was selected whereby genomic DNA of an experimental animal is
subjected to a PCR using primers spanning the nucleotide substitution in exon 3. The primers
were designed complementary to sequences predicted to be in exon 2 and exon 4 according to
the gene map (fig. 5.2). A PCR product produced with these primers was estimated to be
approximately 1.2 kb. The CYP 17 genotype of the animal would determine whether the PCR
fragment possesses or lack the Acs I recognition sequence. Subsequent endonuclease
treatment of the PCR fragment with Acs I should produce DNA fragments that have a distinct
agarose gel banding pattern indicating the CYP 17 genotype of the test subject upon
electrophoresis. A CYP17 heterozygote should produce three DNA fragments, one at the size
of the undigested PCR fragment, and two smaller fragments.
5.3.2 Experimental procedure
A PCR amplification was prepared with genomic DNA template from the CYP17
heterozygote Angora goat described in Chapter 4. Three similar amplification reactions were
performed in a total volume of 50 ,..IlThe primer specifications are listed in appendix A. Pwo
DNA polymerase and dNTPs were purchased from Roche. The PCR reagents were added as
shown in table 5.3. The reaction mixtures were overlaid with mineral oil (Promega) and
amplified as follows: an initial denaturation step at 96°C for 2 min, followed by 30 cycles of
denaturation at 96 °C for 1 min, annealing at 55°C for 75 s, and elongation at 72 °C for 3 min,
final elongation step at 72 °c for 10 min, and further storage of the reactions at -20 oe.
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Table 5.3. PCR amplification reagents with primers targeting the nucleotide substitution in
exon 3 of Angora goat CYP 17.
Reagents Vol. ()lI) Final concentration
dH20 34.75
lOX Buffer (Supplied) 5
dNTPs 5 200 f..lM(Each)
Acs LP (Left-primer) 1.5 600nM
Acs RP (Right-primer) 1.5 600nM
DNA template 2.0
Pwo 0.25 1.25 U
TOTAL 50
Once the amplification reactions were completed the three mixtures were pooled and 30 ul
DNA loading dye added for electrophoresis on a 0.8% preparative agarose gel. DNA
fragments of the predicted size at approximately 1.2 kb were cut from the gel and purified
with an Agarose Gel DNA Extraction Kit (Roche), according to the manufacture's
instructions. The purified DNA was eluted in a total volume of 50 ul water and subsequently
placed in a vacuum oven at 40°C until the DNA was completely dry. Water, 22 ul, was used
to reconstitute the dried DNA, which was then digested (90 min) at 50 DCwith Acs I (4 U)
purchased from Roche in the digest buffer supplied by the manufacturer in a total volume of
25 ul. A second digest was performed with Acs I on the same PCR fragment of the same goat
with 8 units of Acs I and was incubated for three hours at 50 DC.The reaction mixtures were
overlaid with a small drop of mineral oil (Prornega). DNA loading dye, 5 ul, was added to the
reaction mixtures once the digest was completed and then analysed on a 0.8% agarose gel.
5.3.3 Results
Two prominent DNA fragments were produced (fig. 5.3) in the PCR with pnmers
targeting the polymorphic region in exon 3 of Angora goat CYP 17. One of the fragments was
approximately 1.3 kb, close to the predicted size of 1.2 kb. The second fragment had a higher
electrophoretic mobility than any of the fragments of the DNA marker and could be no more
than a few hundred base pairs.
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1 584 bp 1 375 bp
Figure 5.3. Pï.R amplification of the polymorphic region in exon 3 of Angora goat eYPI7.
The amplification reactions (3 X 50 ul) were loaded on a 0.8% preparative agarose gel for
electrophoresis followed by ethidium bromide staining. Lane 1, DNA marker DNAAlEco RI
and DNAAlHind III (Promega); Lanes 2, 3, 4 and 5 received equal amounts of the Pï.R
amplification mixture.
The smaller DNA fragment was likely the product of the Acs LP and Acs RP primers (20
base pairs each) binding to unspecific sequences in the genomic DNA template.
The Acs I digest of the 1.3 kb Pï.R fragment obtained with the Acs LP and Acs RP
primers produced an agarose gel banding pattern as it was predicted for a eYP17
heterozygote Angora goat (fig. 5.4). Half of the peR fragments of a eYP17 heterozygote
should not have the Acs I recognition sequence, while the other half should have the
recognition sequence resulting in the three bands seen in lanes 3 and 4 in fig. 5.4.
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234
564 bp
2027 bp
Figure 5.4. Acs I restriction digest of the peR fragment spanning exon 3 of a heterozygote
eYP17 Angora goat. The restriction digest reactions (20 Ill) were analysed by 0.8% agarose
gel electrophoresis followed by ethidium bromide staining. Lane 1, DNA marker DNAAlHind
III (Prornega); Lane 2, the undigested peR fragment obtained from amplification of exon 3
with the Acs LP an Acs RP primers; Lane 3, Acs LP an Acs RP Pï.R fragment digested with
Acs I (4 U) for 90 min; Lane 4, Acs LP an Acs RP peR fragment digested with Acs I (8 U)
for 3 hrs.
5.4 Discussion
The CYl' 17 genotype test described in this chapter produced results as it was predicted for
a CYl' 17 heterozygote Angora goat. Two peR fragments were produced with the primers
aimed at the G/A nucleotide substitution in exon 3 of eyp17. Only one, however, was near
the predicted size of 1.2 kb (fig. 5.3). It is not surprising that another fragment was amplified
since genomic DNA was used as template and therefore non-specific binding of the primers
was likely to occur.
The first test was done on the genomic DNA of the goat from which the adrenals were
used to synthesize eYP17 cDNA. This goat was believed to might have expressed two
different eYP17 copies because of the two different eYP17 cDNA sequences produced from
its adrenocortical RNA. Therefore any genotype test should produce the same result if indeed
two CYP 17 alleles were present. The agarose gel banding pattern of the Acs I digested peR
fragment was as predicted (fig. 5.4). One fragment was the same size as the undigested Pï.R
Stellenbosch University http://scholar.sun.ac.za
69
fragment and two smaller fragments resulting from Acs I cleavage of half of the PCR
fragments. Further validation for the test was the same result produced by a second Acs I
digest of the same fragment, which received 8 U of Acs I and was incubated for three hours.
This result concluded that the banding pattern was not the result of incomplete digestion by
Acs I.
The genomic copy of the Angora goat CVP 17 gene has not yet been fully sequenced. The
primers designed for amplifying Angora goat CYPI7 mRNA and genomic sequences were
complementary to sheep CYPI7 cDNA sequences since the Boer goat (Capra hircus) cDNA
sequence was not available at the time. These primers worked for all applications except for
amplifying the 5' terminal segment of Angora goat genomic CYPI7. Failure of this PCR,
however, could also have resulted from the right primer being designed across an intron-exon
border. This would prevent the primer from binding properly and thus no fragment will be
amplified. Failure to amplify this segment of the gene could not be due to inadequate binding
of the left primer, since this primer was successfully used to amplify Angora goat CYPI7
cDNA. Another possibility is that the primers were designed to far apart and the polymerase
did not have sufficient time to copy the full length of DNA in the elongation period. A new
PCR strategy for amplifying this segment should, however, solve the problem. Completing
the genomic sequence of the two Angora goat CYPI7 alleles would aid in population
analysis, investigating the origins of the two genes.
The developed CYPI7 genotype test showed that a G/A nucleotide substitution mutation
did indeed occur in exon 3 of the tested Angora goat. Further testing of more goats was now
possible to determine if a true CVP 17 polymorphism existed in Angora goats. Finding a
correlation between a stress susceptible phenotype and anyone of the CYPI7 genotypes is
now a possibility by genotyping Angora goats with different stress susceptible phenotypes.
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CHAPTER6
CYP17 GENOTYPING OF ANGORA GOATS FROM DIFFERENT
POPULATIONS
6.1 Introduction
Previous research indicated that Angora goat adrenals produced abnormally high levels of
androgens at the cost of glucocorticoids [7]. This shift in steroidogenesis is responsible for the
inadequate amounts of cortisol produced by the adrenal cortex. Hypoadrenocorticism is the
condition that develops from such a steroidogenic imbalance. Since three CYP17 genotypes
exist theoretically, they might each induce a unique balance between the metabolic flux
through the Ll5 and Ll4steroid pathways. These pathways lead to androgen and glucocorticoid
production, respectively. This condition is ultimately responsible for the high mortality
among Angora goats suffering from exposure compared to the more hardened Boer goat.
Hypoadrenocorticism in the Angora goat also leads to a high mortality rate among Angora
goat kids, low conception rates and spontaneous abortions in breeding stocks [2]. These
hardships have become synonymous with Angora goat farming. Itwould therefore be of great
value to the farming community if a genetic marker was found for hypoadrenocorticism in the
Angora goat. If a positive correlation could be found between the stress intolerant phenotype
and a CVP 17 genotype, it would strongly suggest that genotype to be a reliable marker.
Using the CYP17 genotype as a marker for stress susceptibility with reasonable certainty
would necessitate that a specific genotype first be correlated with a stress related phenotype.
A test was therefore developed to genotype Angora goats without using adrenal tissue.
Genomic DNA isolated from a blood sample is subjected to a PCR based test to determine the
combination of the two identified CYP17 copies. Since a goat receives one copy of each gene
from each parent, three combinations are possible. A number of goats were subsequently
genotyped. Genotyping was done using Angora goats, which had been categorized into stress
intolerant and stress resistant groups. Goats were obtained from two areas, a designated farm
in the Little Karoo and the Grootfontein experimental farm in the Eastern Cape. The Little
Karoo goats were divided into oily skin and dry skin groups as phenotypic marker for stress
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resistance and stress intolerance respectively. Four of the Grootfontein goats were classified
as either strong or weak reproducers.
The amino terminal of CYP17 contains a proline rich domain (PRD) of 13 amino acids
that is highly conserved among various species (appendix D). This domain is believed to be of
significant importance in correct folding of the enzyme [132,133]. Proline residues may play
an especially important role, as this amino acid normally induces a bend in the peptide
backbone of a protein. Replacement of a proline in the conserved region by site directed
mutagenesis has been shown to cause severe impairment of CYP17 activity [132]. Sequence
analysis of Angora goat CYP17 cDNA identified a possible substitution mutation (Pro41Leu),
in the PRD of the amino terminal (fig. 5.2). A Pro/Leu substitution in this region could have
adverse effects on Angora goat adrenal steroidogenesis. Mapping the Pr041 Leu substitution to
a CYP 17 genotype could therefore aid in understanding a genotype-phenotype correlation.
6.2 CYP17 genotype testing of Angora goats with different stress
susceptible phenotypes
6. 2.1 Introduction
The focus of this study was to find a marker for stress susceptibility in the Angora goat.
Therefore the CYP17 genotype test, which was developed in this study, was used to genotype
several goats from different areas categorized as either stress resistant or stress intolerant. If a
positive correlation was found between a certain CYP 17 genotype and a stress related
phenotype, it would strongly suggest that CYP 17 genotype as a marker for stress
susceptibility in the Angora goat.
Angora goats from the Little Karoo were phenotypically divided into two groups of 10
each for CYP17 genotyping. One group had oily skins and one group had dry skins.
According to an experienced breeder goats with oily skins were much better insulated against
cold compared to dry skin goats and therefore resisted cold stress better. Thus the oily skin
goats are classified as stress resistant and the dry skin goats as stress intolerant. Four Angora
goat ewes from Grootfontein were also selected for genotyping. These goats were classified
as either strong or weak reproducers. This was done by determining the number of foetuses
each ewe carried after impregnation for a number of reproduction cycles. Only one of the four
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ewes was classified as a weak reproducer. Fertility could also be a potential phenotypic
marker for susceptibility to stress, since Angora goat breeding stocks are known to have low
conception rates attributable to the discussed stress intolerance [2]. A further 61 goats from
Grootfontein were genotyped to investigate the distribution of the different CYP 17 alleles.
The identification of two CYP17 alleles in the Angora goat led to speculation that one of
the genes was passed on to the Angora goat from the Boer goat through cross-breeding that
occurred. Therefore six Boer goats were randomly selected from a Little Karoo farm to be
genotyped with the CYP 17 genotype test developed for the Angora goat.
6.2.2 Experimental procedure
Peripheral blood was drawn from all goats to be genotyped directly into EDTA-coated
vacutainer tubes to prevent clotting and DNA damage. Samples were stored at 4 DC.Genomic
DNA was isolated from the blood samples with a Wizard® Genomic DNA Purification Kit
(Promega) according to the manufacturer's instructions. CYP17 genotyping was subsequently
performed on all samples as described in section 5.4.2.
6.2.3 Results
Photos of all agarose gels showing the CYP17 genotyping results for all the goats tested
(89 goats) are shown in appendix E. Some gels do not show DNA markers, since the DNA
fragments indicating the CYP 17 genotype were known to have a lower electrophoretic
mobility than the dye in the loading buffer, which was used to indicate when sufficient
electrophoresis took place. From the 89 goats successfully genotyped in this study the CYP17
homozygote with the Acs I recognition sequence in exon 3 was never identified. The two
identified CYP17 genotypes are designated A-A- and A+A- for the homozygote (without the
Acs I recognition sequence in exon 3) and heterozygote respectively. Genotype results were
obtained for all goats except for two Little Karoo Angora goats. Table 6.1 shows the CYP17
genotype results for the 18 Little Karoo Angora goats, six Boer goats and the four
Grootfontein ewes. CYP 17 genotype results for the Angora goats from Grootfontein that were
not phenotypically categorised are not listed in table 6.1. The CYP 17 genotype distribution
for these goats was 14 homozygotes and 47 heterozygotes. Figure 6.1 shows a typical agarose
gel banding pattern resulting from the CYP17 genotype test for the kA- and A"A- genotypes.
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Table 6.1. Results for the CYP17 genotype test performed on goats from different
populations as indicated.
Origin of Goats Goat no. in Phenotype CYP17 Genotype
Appendix E
1 Dry skin »:»:
2 Oily_skin A+A-
3 / AA-
4 / A-A-
5 / s:»:
6 / »:»:
7 / AA-
8 / A+A-
Little Karoo 9 Oily skin A+A-
Angora 10 D__lYskin »:»:
goats Il / kk
12 / A-A-
13 / AA-
14 / A A-
15 Oily skin AA-
16 Dry skin A-A-
17 / A-A-
18 / A-A-
SI Strong reproducer A+A-
Grootfontein S2 Strong reproducer A+k
Angora goat ewes S3 Strong reproducer AA-
WI Weak rfillToducer AA-
Bl / A+A-
B2 / AA-
Little Karoo B3 / AA-
Boer goats B4 / Ak
B5 / A+A-
B6 / AA-
/ Not available or not relevant - See discussion
Figure 6.1. A 0.8% agarose gel stained with ethidium bromide showing the typical banding
pattern of an A+A- and an A-A- Angora goat as produced by the CYP17 genotype test
described in Chapter 5. Lane 1, an A-A- Angora goat; Lane 2, DNA marker DNAAJEco RI
and DNA",-/ Hind III (Prornega); Lane 3, an A+A-Angora goat.
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6.3 Mapping Pro41 to the A-A- CYP17 genotype
6.3. J Introduction
According to the Angora goat CYP 17 cDNA sequence a Pr041 Leu substitution is found in
the PRD of the amino terminal. It is conceivable that such an amino acid substitution might
have a significant effect on CYP17 activity since it is found in the PRD, a highly conserved
region of CYP17 [132]. It was therefore decided to map either one of the two amino acids
found at position 41 to the A-A- CYP17 genotype. In order to do this, the PRD of genomic
CYP17 of an A-A- CYP17 goat had to be sequenced.
6.3.2 Experimental procedure
A PCR primer was designed downstream of the CIT nucleotide substitution in exon 1. This
primer (Pro/Leu RP) was used together with primer GOO1 to amplify the segment spanning
the PRD of CYP 17. Primer specifications are listed in appendix A. Two PCR amplifications
were performed, one with genomic DNA template from an A-A- CYP17 Angora goat and one
with genomic DNA template from an A+A-CYP17 Angora goat. Pwo DNA polymerase and
dNTPs were purchased from Roche. The PCR reagents were added as shown in table 6.2. All
reactions were overlaid with mineral oil (Promega) and amplified as follows: an initial
denaturation step at 96°C for 2 min, followed by 30 cycles of denaturation at 96 -c for 1 min,
annealing at 55°C for 75 s, and elongation at 72°C for 3 min, final elongation step at 72 "C
for 10min, and further storage of the reactions at -20 °C.
Table 6.2. PCR amplification reagents with primers targeting exon 1 of Angora goat CYP17.
Reagents Vol. (,.d) Final concentration
dH20 74.5
lOX Buffer (Supplied) 10
dNTPs 10 200 f.lM(Each)
GOO1 (Left primer) l.5 300nM
Pro/Leu RP (Right primer) l.5 300nM
DNA template 2.0
Pwo 0.5 2.5 U
TOTAL 100
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DNA loading dye, 20 ul, was added to the amplification mixture once the reaction was
completed and then loaded on a 0.8% preparative agarose gel for electrophoresis. A DNA
fragment produced by the PCR amplification was cut from the gel and purified with a
Agarose Gel DNA Extraction Kit from Roche according to the manufacturer's instructions.
The purified DNA fragments were sequenced as described in section 4.3.2 using 13.3 ng/ul of
template DNA and 1.1 ng/ul of primer DNA per sequencing reaction. The right primer used
in the PCR amplification was used for sequencing the fragment.
6.3.3 Results
DNA sequences of CYP17 exon 1 were produced for an A+A and an AA Angora goat
(fig. 6.2). The graphic nucleotide sequences clearly show a double peak at position 122 of
exon 1 for the A+A Angora goat and a single peak at position 122 for the AA Angora goat.
A cytosine peak was found at position 122 for the AA Angora goat, which coded for Proline
at position 41 in the CVP 17 peptide.
o 0 C C A l~O 0 TeT 0 0 0 0 A llf 0 ,.. A C
130 14)
NOCAOOCTOCCCACC",OOOO C
A err: Praline/Le cine
o 0 C C A lbO 0 TeT .... l~ 0 A A COO C 130 1-40AO OCTOCCCACCAOOO 0 C
B t: Proljne
v n n
A A
AA1\ ~ P hh0c 0., ,mV>.
Figure 6.2. Graphic nucleotide sequences of Angora goat genomic CVP 17 (exon 1). Graph A
shows the sequence of an A'A'Angora goat and graph B of an AA Angora goat. Position 125
in both sequences corresponds to position 122 of exon 1.
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6.4 Discussion
Development of a CYP 17 genotype test for the Angora goat enabled the screening of 83
Angora goats and six Boer goats. One aim of this experiment was to find a possible
correlation between the different CYP 17 genotypes, and a physical characteristic of the
Angora goat associated with stress intolerance. Finding such a correlation could help in
breeding programmes aimed at producing more hardened Angora goats. Six Boer goats were
also genotyped to see wether they also carried a second CYP 17 allele. This was done because
Boer goats have been used in the past in breeding programs with Angora goats. The Boer
goat, although not a good fleece producer, has many properties aiding its adaptation to
extreme environmental conditions. Cross-breeding was aimed at introducing these qualities
into Angora goat populations. Although a hardened cross-breed was produced, these goats
never produced the same quality of fleece as purebred Angora goats. Furthermore the six
Boer goats genotyped produced the same size PCR product as the Angora goats, which upon
digestion with Acs I showed the same agarose gel banding pattern after electrophoresis as a
CYP17 heterozygote Angora goat. These results certainly lay the foundation for further
investigation into the presence of two CYP 17 genes in the Boer goat.
Results were obtained for a total of 83 Angora goats and six Boer goats after genotyping
84 Angora goats and six Boer goats. One Angora goat blood sample was lost and another
failed to produce a PCR product. All the Grootfontein Angora goats were heterozygotes. Only
one, however, was identified as a weak reproducer. Unfortunately this goat had the same
CYP17 genotype as the three strong reproducers. No substantiated conclusion could therefore
be made from this result alone. It could, however, be speculated that CYP17 heterozygotes
are strong reproducers. After the genotype tests for the Little Karoo Angora goats were
completed, the breeder was only able to conclusively categorize six of the 20 goats he
provided in terms of oily and dry skin. This was unfortunate, since the statistical analyses of
the results were compromised. However, a positive correlation was seen among six of the
goats (table 6.1). Three had oily skins and three dry skins. The three oily skin goats were
heterozygotes and the three dry skin goats were homozygotes. According to the breeder the
oily skin goats are hardened compared to the dry skin goats.
The goat described in Chapter 4 from which the CYP17 cDNA was prepared had also been
described as hardened. It therefore seems that there is a correlation between the A+A-CYP 17
genotype and the properties generally observed in hardened Angora goats. Whether the A-A-
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CYP17 genotype (without the Acs I recognition sequence in exon 3) could serve as a marker
for hypoadrenocorticism could not conclusively be determined from these results. The current
evidence would, however, suggest it to be a good candidate marker. Biochemical analysis of
the two different CYP17 enzymes encoded by the different CYP17 genes could clarify the
role of CVP 17 in hypoadrenocorticism in the Angora goat.
If it is assumed that only the two alleles identified for the Angora goat and Boer goat
CYP17 gene exist, the gene could be termed polymorphic. This is because in the population
of 83 Angora goats successfully genotyped, both alleles have a significant frequency. If the
two CYP17 alleles are designated A- and A+, and the homozygote identified is A-A-, then the
allelic frequencies for A- and A+ can be calculated with the formula P(A- ) = OSP(A+A-) +
P(A-A-) where peA+k) and P(A-A- ) are the respective genotypic frequencies and P(A- ) the
A- allelic frequency. For A+ the equation would be, P(A+) = OSP(A+A-) + P(A+A+) where
peA+) is the allelic frequency for A+ and peA+A+) the genotypic frequency for the unidentified
A+A+genotype. From the genotype results P(kA-) and P(A+A-) are calculated as 24/83 = 0.29
and 59/83 = 0.71 respectively. The genotypic frequencies, for any polymorphic gene in a
population, must add up to 1 [135]. The allelic frequencies can now be calculated as: P(A- ) =
0.5·(0.71) + 0.29 = 0.645 and P(A+) = OS(0.71) + 0.0 = 0.355 (the A+A+ genotype was not
identified in the tested population, therefore the 0.0 value in the latter equation).
If a Hardy-Weinberg relation existed between the allelic and genotypic frequencies, the
A+A+genotype would have a frequency ofO.35S2 = 0.126. However, factors such as mutation,
genetic drift, gene flow and selection all alter the Hardy-Weinberg relation between genotypic
and allelic frequency. The number of Angora goats tested in this study is relatively small and
the interpretations made in terms of population genetics are therefore limited. The A+A+
genotype that was not identified could possibly be lethal. Should that be the case, the A+k
CYP17 genotype must have a selective advantage above the A-A- genotype for it to have such
a high genotypic frequency. It could be argued that if the CVP 17 heterozygote does not cause
hypoadrenocorticism, or at least not a severe form thereof, it could produce the selective
advantage that would explain its high genotypic frequency.
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CHAPTER 7
GENERAL DISCUSSION
The mm of this study was to further investigate the underlying mechanism of
hypoadrenocorticism in the South African Angora goat. Engelbrecht et al. previously
identified hypoadrenocorticism as the primary cause of the Angora goat's inability to
withstand exposure to extreme environmental conditions [2]. It has been a long time since
reduced adrenal function was diagnosed in habitually aborting Angora goats [141]. The
reduced adrenal function is responsible for the observed hypoadrenocorticism in the Angora
goat, which ultimately results in inadequate cortisol release from the adrenal cortex in
response to HPA-axis stimulation.
Previous research on Angora goats showed an abrupt drop in blood glucose concentrations
to be largely responsible for insufficient body heat production in the cold stressed Angora
goat [6]. Cold stress activates the HPA-axis. This is followed by the release of CRH from the
hypothalamus, which stimulates the corticotrophes of the anterior pituitary to secrete ACTH
into the general circulation. ACTH then binds to its membrane bound receptor in the adrenal
cortex and activates various intracellular signaling pathways. This activation promotes the
biosynthesis and release of the glucocorticoids. Glucocorticoid release from the adrenal cortex
is a central event in the mammalian response to stress [142]. The ability of glucocorticoids to
counteract the manifestations of noxious stimuli helps both man and animal to cope with a
wide variety of stresses encountered in everyday life. Any physiological or pathological
condition that impairs the glucocorticoid response to stress could have severe implications for
an organism if the stressful stimulus is intense and present for long periods of time.
To many farmers Angora goat farming in South Africa is synonymous with large numbers
of goats that easily succumb to exposure during cold wet winter nights. The reason for this is
the inability of the goats to produce sufficient body heat. This problem has received a great
deal of attention from various research groups. It is generally accepted that the hypoglycemia,
induced in the Angora goat by cold stress, precipitates hypothermia. Finally hypothermia
causes central collapse and death follows. Wentzel developed an alkali-ionophore-treated
whole grain that improved the animal's energy status, which aided in body heat production
during cold stress [143]. This nutrient supplement strategy towards combating the Angora
goat's susceptibility to cold stress was, however, not financially viable. A better understanding
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of the molecular mechanisms of hypoadrenocorticism could therefore aid in farming with and
breeding of Angora goats. It was strongly believed that a genetic predisposition to stress
susceptibility might exist in the Angora goat. This prompted an investigation into the CYP17
gene of the Angora goat.
cDNA of the Angora goat CYP17 gene was synthesized by isolating total RNA and
mRNA from a randomly selected Angora goat. Sequence analysis of the cDNA produced two
unique sequences differing only by four isolated DNA nucleotides. These results indicated the
possibility that two copies of the CYP17 mRNA were expressed in the adrenal cortex of a
single Angora goat. A possible CVP 17 heterozygote was thus identified in a small Angora
goat breeding stock in the Western Cape. Both Angora goat CVP 17 sequences consisted of a
1 530 bp coding region from the ATG translational start to the TGA translational stop site.
However, these sequencing anomalies could have been caused by the reverse transcriptase
during synthesis of the cDNA since this enzyme is not subject to a high degree of stringency.
Therefore the CVP 17 genotype test was developed, which successfully genotyped several
goats and also proved the nucleotide substitution at position 637 (cDNA sequence) to be a
true mutation. Furthermore the CIT nucleotide substitution at position 122 is also believed to
be a true mutation. This is because exon 1 of a CYP17 homozygote and heterozygote (as
identified by the genotype test described in Chapter 5) Angora goat was sequenced using
genomic DNA as template. The sequencing templates for these reactions were produced by
conventional PCR, which was preformed using a proofreading thermostable polymerase. This
enzyme, unlike the reverse transcriptase, is subject to a high degree of stringency. The
homozygote produced only a C peak at position 122 and the heterozygote produced a double
CIT peak, as was originally shown from the cDNA sequence. Whether this mutation is linked
with or segregated from the G/A substitution mutation at position 637 is undetermined. To
determine this exon 1 of many more CYP17 homozygote Angora goats (Acs I tested) need to
be sequenced. The other two possible base mutations have not been investigated and can thus
not be confirmed as true mutations Sequencing of the cloned Angora goat CYP17 cDNA
constructs could, however, confirm those nucleotide substitution mutations and assure the
correct assignment of each base to the right CVP 17 allele.
Cloning of the two Angora goat CVP 17 cDNA constructs has, to date, been unsuccessful.
However, a CYP17 cDNA sequence is available on GENBANK for Capra hircus, the Boer
goat. This sequence is 100% homologous to the Angora goat (Capra aegagrus) sequences
generated in this study, except for the four loci with the substituted bases. Furthermore, the
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bases at the four loci differing in the two Angora goat sequences are in the Boer goat always
one of the two nucleotides identified in the heterozygote Angora goat. It therefore strongly
suggests that the one Angora goat CYP17 cDNA sequence would be identical to the Boer
goat sequence. This likelihood is further supported by the cross-breeding practices that
occurred between Angora goat and Boer goat breeding stocks.
Identification of a CYP 17 heterozygote Angora goat theoretically implied the existence of
two homozygote CYP17 genotypes. To identify such possible homozygote genotypes, several
goats had to be screened for the different CYP17 combinations. This was done by the
genotype test as described in Chapter 5. A further objective was to find a possible correlation
between the CYP 17 genotypes and a phenotype associated with either stress tolerance or
stress intolerance. For this purpose some Angora goats were categorized according to certain
stress related phenotypes and then genotyped. From the 89 goats genotyped in this study, the
CYP 17 homozygote without the Acs I recognition sequence in exon 3 was never identified.
Of all the Angora goats genotyped, 20 were from the Little Karoo. An attempt was made
to categorize them phenotypically according to whether they had oily or dry skins, but only
six were confidently categorized, three with oily skins, associated with stress tolerant
characteristics, and three with dry skins, associated with stress intolerant characteristics. Of
the 20 goats only 18 were successfully genotyped. Although statistically inconclusive, there
was a 100% genotype to phenotype correlation for the six goats that were successfully
identified according to their phenotypes. The three oily skin goats were CYP 17 heterozygotes,
and the three dry skin goats were homozygotes. The four ewes from the Grootfontein
agricultural research farm were all CYP 17 heterozygotes. Of these goats one was a weak
reproducer and the other strong reproducers. Although thus far only a small number of goats
have been genotyped, it seems likely that the identified CYP 17 heterozygote genotype is
associated with a more hardened phenotype among Angora goats.
It should further be noted that all the goats tested were adults. The allelic and genotypic
frequencies therefore only extend to the adult Angora goat population. Hypoadrenocorticism,
however, is responsible for high kid mortality and high numbers of spontaneous abortions
among pregnant ewes [2]. If a CYP17 genotype is responsible for the fatalities among young
goats and the abortions, CYP17 genotype frequencies will very likely differ in a population of
Angora goat kids and aborted embryos. Further investigations should therefore determine the
CYP 17 genotype of aborted fetuses and young goat corpses.
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Sequence results from the Angora goat CYP17 cDNA revealed four possible DNA
nucleotide substitutions between the two copies. Of these only three translated into amino
acid substitutions. One of these amino acid substitutions at amino acid position 41 from the
amino terminal of the protein is in a highly conserved region of CYP17 [133]. Furthermore,
this amino acid substitution is caused by the nucleotide substitution in exon 1 of Angora goat
CYP 17, which is believed to be a true mutation. This 13 amino acid conserved stretch (amino
acid 32 to 44) is called the proline rich domain (PRD). The PRD is believed to play an
important role in the correct folding of the enzyme, especially by stabilizing the conformation
before heme binding [132,133]. Substitution of the prolines in this region for other amino
acids through site directed mutagenesis greatly impairs CYP17 activity. Of the two CYP17
copies identified in the Angora goat, one has a proline at position 41 and the other a leucine.
Sequencing data from the genomic copy of CYP17 from a CYP17 homozygote Angora
goat mapped the proline at position 41 to the CYP17 homozygote identified in this study.
Furthermore, this CYP 17 homozygote seems to produce a more stress intolerant phenotype
associated with hypoadrenocorticism. If the leucine at position 41 were to abolish or
significantly impair CYP 17 activity, the A+A+ genotype (leucine at position 41) would hardly
be associated with hypoadrenocorticism that is caused by a heightened flux by CYP17
through the il5 steroid pathways. The same premise would explain why the CYP 17
heterozygote produces a lower flux through the il5 steroid pathway compared to the identified
A-A- homozygote. This would explain why the identified CYP17 homozygotes are those
bearing characteristics associated with hypoadrenocorticism.
Any predictions made regarding the influence a specific Angora goat CYP 17 mutation
could have on adrenal steroidogenesis are purely speculative. For such conclusions to be
made, the enzyme kinetics and substrate specificity of the two different CYP 17 enzymes
encoded, will have to be done through in vitro expression and analysis.
The six genotyped Boer goats were all CYP17 heterozygotes. Although no A-A-
homozygotes were identified among Boer goats they are believed to exist, since only a very
small number of Boer goats were tested. The Boer goat population in the Eastern Cape is very
hardened. It should be noted that one genetic variant that causes a stress intolerant phenotype
in one species would by no means necessarily have the same effect in another. Furthermore,
the GENBANK sequence for Capra hircus (Boer goat) CYP17 cDNA made no mention of a
polymorphism and showed a leucine at position 41.
Stellenbosch University http://scholar.sun.ac.za
82
In the final analysis it would seem that the different CYP17 genotypes present in the South
African Angora goat population could possibly contribute to the stress intolerant phenotype.
The only way in which a CYP17 genotype could precipitate such an effect is to alter the
balance of adrenocortical steroid output. This is well in accordance with the previously
identified hypoadrenocorticism in the Angora goat. This condition does indeed cause a shift in
the flux through the steroidogenic pathways, and ultimately results in inadequate cortisol
release from the adrenal cortex [7]. The two cDNA constructs encoding Angora goat CYP17
are still not cloned. This needs to be done before the two enzymes could be expressed
separately in non-steroidogenic tissue culture. In vitro studies of the activities of the different
CYP17 enzymes encoded by the two cDNA constructs, would conclusively confirm whether
a CYP17 genotype is responsible for the altered steroidogenic output in the Angora goat
adrenal. It could further predict to what extent any of the three CYP 17 genotypes could confer
hypoadrenocorticism to an Angora goat.
The CYP17 genotype test developed in this study now enables those investigating the
stress susceptibility of the Angora goat to further interpret their findings in terms of a genetic
variation strongly believed to influence the Angora goat's stress response. Engelbrecht et al.
made the first contributions towards understanding the molecular mechanism of the Angora
goat's impaired stress response [7]. With a better understanding today of
hypoadrenocorticism, as seen in the Angora goat, and also with the knowledge of the genetic
polymorphism found in a gene involved with adrenal steroidogenesis more focused research
strategies can be developed. This study has identified at least two Angora goat CYP 17 alleles.
However, more might exist since four nucleotide substitutions were detected in the cDNA
sequence of which only two were shown to be true mutations. The foundation is thus laid by
this work for further in depth investigations into Angora goat CYP17 allelic distributions.
To obtain more reliable numbers for the allelic frequencies in the Angora goat population
of the two identified CYP17 alleles, many more goats need to be genotyped. Such testing
could provide useful information about the distribution of stress intolerance compared to that
of the different CYP 17 genotypes. It is also important that consensus be reached as to what
physical properties indeed produce a hardened goat for such testing to have any significance.
Whether selecting for a specific CYP 17 genotype produces a more hardened goat that still
produces fleece of sufficient quality remains to be seen.
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APPENDIX A
Primer name Primer sequence
RT-PCR primers
GOOI LP
G006RP
5' -ACGCGTCGACGCCACTCCACAGCTCTITGT-3'
5' -GGAGGAAGAAGGAA TGGTGG-3'
eDNA sequence primers
GOOI LP 5'-ACGCGTCGACGCCACTCCACAGCTCTTTGT-3'
G021LP
G031LP
G006 RP
G026 RP
G036 RP
5' -GCTTT ATCTGCTTCAACTTC-3'
5' -GCTATCA TTGACTCCAGCA T-3'
5' -GGAGGAAGAAGGAA TGGTGG-3'
5' -GGTCAA TGCTATCCTGGA TC-3'
5' -GCCA TCCTTGAACAGGGCAA-3'
CYP17 genomic PCR primers
GOOI LP 5'-ACGCGTCGACGCCACTCCACAGCTCTITGT-3'
G002 RP
G003 LP
G004RP
G005 LP
G006RP
5'-GCTGA TTATGTTGGTGACCG-3'
5' -ACGCGTCGACTCCATAGATCTGTCCGAGCC-3'
5' -GTTCCGGTCACTGA TGGTTG-3'
5' -ACGCGTCGACTGCTACACCA TCCTTCGTTG-3'
5' -GGAGGAAGAAGGAA TGGTGG-3'
CYP17 genomic sequence primers
G003 LP 5'- ACGCGTCGACTCCATAGATCTGTCCGAGCC-3'
GI03 LP
G004 RP
0104 RP
G005 LP
GI05 LP
G006RP
GI06 RP
5' -ATTGCAGGCAGAGACTTTT A-3'
5'- GTTCCGGTCACTGATGGTTG-3'
5' -CACTTGGGCCCTTTTT AAAA-3'
5' - ACGCGTCGACTGCTACACCATCCTTCGTTG-3'
5' -CAAGCTGGCTGGTCAAACCT -3'
5' - GGAGGAAGAAGGAA TGGTGG-3'
5'-GAAGGGGAAATTGGGAAACC-3'
CYP17 genotyping primers
Acs LP 5'-GACATCCTGTCAGACAACCA-3'
AcsRP 5'-TITCAACACAACCCTTCATC-3'
Genomic CYP17 amino terminal PCR primers
GOOI LP 5'-ACGCGTCGACGCCACTCCACAGCTCTITGT-3'
Pro/Leu RP 5' -GACATCCTGTGAGACAACCA-3'
Pro -+ Leu mapping sequence primer
Pro/Leu RP 5' -GACA TCCTGTGAGACAACCA-3'
LP - Left primer
RP - Right primer
All primers used were dissolved in water
95
Target area
Targeted upstream of CYPI7 ATG start site
Targeted downstream of CVP 17 TGA stop site
First anti-sense primer: 5' terminal
Second anti-sense primer: 5' terminal
Third anti-sense primer: middle segment
First sense strand primer: middle segment
Second sense strand primer: 3' terminal
Third sense strand primer: 3' terminal
Targeted at 5' terminal of genornic CYPl7
Targeted at 5' terminal of genomic CYPI7
Targeted at middle segment of genomic CYPl7
Targeted at middle segment of genomic CYPI7
Targeted at 3' terminal of genomic CVP 17
Targeted at 3' terminal of genomic CVP 17
First anti-sense primer: middle segment
Second anti-sense primer: middle segment
First sense primer: middle segment
Second sense primer: middle segment
First anti-sense primer: 3' terminal
Second anti-sense primer: 3' terminal
First sense primer: 3' terminal
Second sense primer: 3' terminal
Targeted at exon 2 of genomic CVP 17
Targ~ted at exon 4 of genomic CYPI7
Targeted upstream ofCYPI7 ATG start site
Targeted at exon I of CVP 17
Sense primer: CYPl7 exon I
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APPENDIXB
Angora 1 and Angora 2 represent the two CYP 17 cDNA sequences and Goat represents the
Capra hircus CYP17 cDNA sequence. The Angora goat nucleotide bases that differ from the
goat sequence are indicated with red arrows. The Acs I recognition sequence is indicated in
blue (bp 635).
10 20 30 40 50
••.. I .... I .... I .... I .... I .... I .... I .... I .... I .... I
Angora 1 ATGTGGGTGCTCTTGGGTGTCTTTCTGCTCACCCTCGCCTATTTATTTTG 50
Goat ATGTGGGTGCTCTTGGGTGTCTTTCTGCTCACCCTCGCCTATTTATTTTG 50
Angora 2 ATGTGGGTGCTCTTGGCTGTCTTTCTGCTCACCCTCGCCTATTTATTTTG 50
60 t 70 80 90 100
.... I .... I .... I .... I ..•. I .... I .... I .... I .... I .... I
Angora 1 GCCCAAGACCAAGCACTCTGCTGCCAAGTACCCCAGAAGCCTCCCATCCC 100
Goat GCCCAAGACCAAGCACTCTGCTGCCAAGTACCCCAGAAGCCTCCCATCCC 100
Angora 2 GCCCAAGACCAAGCACTCTGCTGCCAAGTACCCCAGAAGCCTCCCATCCC 100
110 120 130 140 150
.•.. I .... I ...• I ...• I .... I .•.. I .... I •... I .... I •... I
Angora 1 TGCCCCTGGTGGGCAGCCTGCTGTTCCTCCCCAGACGTGGCCAGCAACAC 150
Goat TGCCCCTGGTGGGCAGCCTGCTGTTCCTCCCCAGACGTGGCCAGCAACAC 150
Angora 2 TGCCCCTGGTGGGCAGCCTGCCGTTCCTCCCCAGACGTGGCCAGCAACAC 150
160 170t 180 190 200
.•.• I ••.. I .•.. I .... I ..•. I .... I .... I ••.. I .... I .... I
Angora 1 GAGAACTTCTTCAAGCTGCAGGAAAAATATGGCCCCATCTATTCCTTTCG 200
Goat GAGAACTTCTTCAAGCTGCAGGAAAAATATGGCCCCATCTATTCCTTTCG 200
Angora 2 GAGAACTTCTTCAAGCTGCAGGAAAAATATGGCCCCATCTATTCCTTTCG 200
210 220 230 240 250
•••. I ...• I ..•. I ...• I ••.. I ...• I .... I ..•. I .... I .... I
Angora 1 TTTGGGTTCCAAGACTACTGTGATGATTGGACACCACCAGTTGGCCAGGG 250
Goat TTTGGGTTCCAAGACTACTGTGATGATTGGACACCACCAGTTGGCCAGGG 250
Angora 2 TTTGGGTTCCAAGACTACTGTGATGATTGGACACCACCAGTTGGCCAGGG 250
260 270 280 290 300
.... I .... I ••.. I •... I .... I •... I ..•• I .••. I .... I •... I
Angora 1 AGGTGCTTCTCAAGAAGGGCAAGGAATTCTCTGGGCGTCCCAAAGTGGCC 300
Goa t AGGTGCTTCTCAAGAAGGGCAAGGAATTCTCTGGGCGTCCCAAAGTGGCC 300
Angora 2 AGGTGCTTCTCAAGAAGGGCAAGGAATTCTCTGGGCGTCCCAAAGTGGCC 300
310 320 330 340 350
.... I ..•. I .•.. I •.•• I ••.. I .... I ..•. I •... I •••. I .... I
Angora 1 ACTCTAGACATCCTGTCAGACAACCAAAAGGGCATTGCCTTTGCCGACCA 350
Goat ACTCTAGACATCCTGTCAGACAACCAAAAGGGCATTGCCTTTGCCGACCA 350
Angora 2 ACTCTAGACATCCTGTCAGACAACCAAAAGGGCATTGCCTTTGCCGACCA 350
360 370 380 390 400
•••• I .... I .... I •••• I ••.. I .... I .•.. I •..• I •... I •.•. I
Angora 1 TGGTGCCCACTGGCAGCTGCATCGGAAGCTGGTACTGAATGCCTTTGCCC 400
Goat TGGTGCCCACTGGCAGCTGCATCGGAAGCTGGTACTGAATGCCTTTGCCC 400
Angora 2 TGGTGCCCACTGGCAGCTGCATCGGAAGCTGGTACTGAATGCCTTTGCCC 400
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410 420 430 440 450
.••• I •... I ...• I ••.. I ••.• I •••. I •••• I ..•. I ...• I .•.• I
Angora 1 TGTTCAAGGATGGCAACCTGAAGTTAGAGAAGATCATTAATCAGGAAGCC 450
Goat TGTTCAAGGATGGCAACCTGAAGTTAGAGAAGATCATTAATCAGGAAGCC 450
Angora 2 TGTTCAAGGATGGCAACCTGAAGTTAGAGAAGATCATTAATCAGGAAGCC 450
460 470 480 490 500
.•.• I .•.• I .•.• I ••.. I •••. I •••• I •••• I ..•. I .... I .••. I
Angora 1 AACGTGCTGTGTGATTTCCTGGCTACCCAGCATGGACAGTCCATAGATCT 500
Goat AACGTGCTGTGTGATTTCCTGGCTACCCAGCATGGACAGTCCATAGATCT 500
Angora 2 AACGTGCTGTGTGATTTCCTGGCTACCCAGCATGGACAGTCCATAGATCT 500
510 520 530 540 550
.... I •.•• I •.•• I ..•• I •••• I .••. I ••.. I •.•. I .•.. I .•.. I
Angora 1 GTCCGAGCCTCTCTCTCTGGCGGTCACCAACATAATCAGCTTTATCTGCT 550
Goat GTCCGAGCCTCTCTCTCTGGCGGTCACCAACATAATCAGCTTTATCTGCT 550
Angora 2 GTCCGAGCCTCTCTCTCTGGCGGTCACCAACATAATCAGCTTTATCTGCT 550
560 570 580 590 600
••.. I ...• I ..•. I .... I .... I •... I •... I ..•• I •..• I .•.. I
Angora 1 TCAACTTCTCCTTCAAGAATGAGGATCCTGCCCTGAAGGCCATACAAAAT 600
Goat TCAACTTCTCCTTCAAGAATGAGGATCCTGCCCTGAAGGCCATACAAAAT 600
Angora 2 TCAACTTCTCCTTCAAGAATGAGGATCCTGCCCTGAAGGCCATACAAAAT 600
610 620 630 640 650
•••• I •••. I •••. I •••• I •••• I •.•• I ..•• I •••. I •••• I •••. I
Angora 1 GTCAATGATGGCATCCTGGAGGTTCTGAGCAAGGAAATTCTGTTAGACAT 650
Goat GTCAATGATGGCATCCTGGAGGTTCTGAGCAAGGAAATTCTGTTAGACAT 650
Angora 2 GTCAATGATGGCATCCTGGAGGTTCTGAGCAAGGAAGTTCTGTTAGACAT 650
t 690660 670 680 700
.•.. I ••.. I ••.• I •.•. I .•.. I ..•. I .••• I .... I ..•. I .... I
Angora 1 ATTCCCTGCGCTGAAGATTTTCCCCAGCAAAGCCATGGAAAAGATGAAGG 700
Goat ATTCCCTGCGCTGAAGATTTTCCCCAGCAAAGCCATGGAAAAGATGAAGG 700
Angora 2 ATTCCCTGCGCTGAAGATTTTCCCCAGCAAAGCCATGGAAAAGATGAAGG 700
710 720 730 740 750
••.. I .••• I .••. I .•.. I ..•. I •..• I ..•• I ..•. I .... I .•.. I
Angora 1 GTTGTGTTGAAACGCGAAATGAATTGCTGAATGAAATCCTTGAAAAATGT 750
Goat GTTGTGTTGAAACGCGAAATGAATTGCTGAATGAAATCCTTGAAAAATGT 750
Angora 2 GTTGTGTTGAAACGCGAAATGAATTGCTGAATGAAATCCTTGAAAAATGT 750
760 770 780 790 800
•... I ..•. I •••• I •••• I •••• I •..• I •... I .... I •.•. I •••. I
Angora 1 CAGGAGAACTTCACCAGCGACTCCATCACTAACTTGCTGCACATACTGAT 800
Goat CAGGAGAACTTCACCAGCGACTCCATCACTAACTTGCTGCACATACTGAT 800
Angora 2 CAGGAGAACTTCACCAGCGACTCCATCACTAACTTGCTGCACATACTGAT 800
810 820 830 840 850
•••• I •••. I .... I .••. I .••• I •.•• I .•.• I •.•• I ••.. I •..• I
Angora 1 GCAAGCCAAGGTGAATGCAGACAATAACAACGCTGGCCCAGACCAGGATT 850
Goat GCAAGCCAAGGTGAATGCAGACAATAACAACGCTGGCCCAGACCAGGATT 850
Angora 2 GCAAGCCAAGGTGAATGCAGACAATAACAACGCTGGCCCAGACCAGGATT 850
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860 870 880 890 900
.... I •..• I •... I ..•. I .... I .... I ••.. I .... I .... I .... I
Angora 1 CAAAGCTGCTTTCAAACAGACACATGCTCGCTACCATAGCGGACATCTTC 900
Goa t CAAAGCTGCTTTCAAACAGACACATGCTCGCTACCATAGCGGACATCTTC 900
Angora 2 CAAAGCTGCTTTCAAACAGACACATGCTCGCTACCATAGCGGACATCTTC 900
910 920 930 940 950
.... I ..•. I .... I •... I .... I .... I .... I .... I .... I .... I
Angora 1 GGGGCTGGTGTGGAGACCACCACCTCTGTGATAAAGTGGATCGTGGCCTA 950
Goat GGGGCTGGTGTGGAGACCACCACCTCTGTGATAAAGTGGATCGTGGCCTA 950
Angora 2 GGGGCTGGTGTGGAGACCACCACCTCTGTGATAAAGTGGATCGTGGCCTA 950
960 970 980 990 1000
...• I •... I ••.• I .... I .•.. I .••. I .... I .... I .•.. I .... I
Angora 1 CCTGCTACACCATCCTTCGTTGAAGAAGAGGATCCAGGATAGCATTGACC 1000
Goat CCTGCTACACCATCCTTCGTTGAAGAAGAGGATCCAGGATAGCATTGACC 1000
Angora 2 CCTGCTACACCATCCTTCGTTGAAGAAGAGGATCCAGGATAGCATTGACC 1000
1010 1020 1030 1040 1050
••.• I ...• I ••.. I •... I ..•• I ...• I ...• I •••. I .... I ••.. I
Angora 1 AGAATATAGGTTTCAATCGCACCCCAACCATCAGTGACCGGAACTGCCTT 1050
Goat AGAATATAGGTTTCAATCGCACCCCAACCATCAGTGACCGGAACTGCCTT 1050
Angora 2 AGAATATAGGTTTCAATCGCACCCCAACCATCAGTGACCGGAACTGCCTT 1050
1060 1070 1080 1090 1100
.... I ..•. I .•.• I ...• I ••.. I .•.• I •••• I •.•. I .... I .•.. I
Angora 1 GTCCTGCTGGAGGCGACCATCCGAGAGGTGCTCCGAATCCGGCCTGTGGC 1100
Goat GTCCTGCTGGAGGCGACCATCCGAGAGGTGCTCCGAATCCGGCCTGTGGC 1100
Angora 2 GTCCTGCTGGAGGCAACCATCCGAGAGGTGCTCCGAATCCGGCCTGTGGC 1100
1110 t 1120 1130 1140 1150
.... I .... I .... I ••.. I .... I •... I ••.. I .... I .... I .... I
Angora 1 CCCTATGCTGATCCCCCACAAGGCTATCATTGACTCCAGCATTGGCGACC 1150
Goat CCCTATGCTGATCCCCCACAAGGCTATCATTGACTCCAGCATTGGCGACC 1150
Angora 2 CCCTATGCTGATCCCCCACAAGGCTATCATTGACTCCAGCATTGGCGACC 1150
1160 1170 1180 1190 1200
.... I .... I .•.. I •.•. I .... I ..•. I .... I •... I .... I .... I
Angora 1 TTACCATTGACAAGGGCACAGACGTTGTGGTCAACCTGTGGGCACTGCAT 1200
Goat TTACCATTGACAAGGGCACAGACGTTGTGGTCAACCTGTGGGCACTGCAT 1200
Angora 2 TTACCATTGACAAGGGCACAGACGTTGTGGTCAACCTGTGGGCACTGCAT 1200
1210 1220 1230 1240 1250
.••. I .... I •... I .... I •..• I •... I ••.. I ••.• I ...• I .... I
Angora 1 CACAATGAGAAGGAGTGGCAGCAGCCCGACCTGTTCATGCCCGAGCGCTT 1250
Goa t CACAATGAGAAGGAGTGGCAGCAGCCCGACCTGTTCATGCCCGAGCGCTT 1250
Angora 2 CACAATGAGAAGGAGTGGCAGCAGCCCGACCTGTTCATGCCCGAGCGCTT 1250
1260 1270 1280 1290 1300
•••• I •..• I .•.• I •••• I ••.• I .... I •••. I •••• I •••• I •.•. I
Angora 1 CTTGGACCCCACGGGGACACAACTCATCTCGCCATCGTTAAGCTACTTGC 1300
Goat CTTGGACCCCACGGGGACACAACTCATCTCGCCATCGTTAAGCTACTTGC 1300
Angora 2 CTTGGACCCCACGGGGACACAACTCATCTCGCCATCGTTAAGCTACTTGC 1300
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1310 1320 1330 1340 1350
· •.. I .... I .... I .... I ...• I .... I .... I .... I .... I .... I
Angora 1 CCTTTGGAGCTGGACCCCGCTCCTGTGTAGGTGAGATGCTAGCCCGCCAG 1350
Goat CCTTTGGAGCTGGACCCCGCTCCTGTGTAGGTGAGATGCTAGCCCGCCAG 1350
Angora 2 CCTTTGGAGCTGGACCCCGCTCCTGTGTAGGTGAGATGCTAGCCCGCCAG 1350
1360 1370 1380 1390 1400
· ... I .... I .... I .... I .... I .... I .... I .... I .... I .... I
Angora 1 GAGCTCTTCCTCTTCATGTCCCGGCTGCTGCAGAGGTTCAACCTGGAGAT 1400
Goat GAGCTCTTCCTCTTCATGTCCCGGCTGCTGCAGAGGTTCAACCTGGAGAT 1400
Angora 2 GAGCTCTTCCTCTTCATGTCCCGGCTGCTGCAGAGGTTCAACCTGGAGAT 1400
1410 1420 1430 1440 1450
· ... I .... I .... I .... I .... I .... I .... I .... I .... I .... I
Angora 1 CCCGGATGATGGGAAGCTACCCTCTCTGGAGGGCAATCCCAGTCTCGTCT 1450
Goat CCCGGATGATGGGAAGCTACCCTCTCTGGAGGGCAATCCCAGTCTCGTCT 1450
Angora 2 CCCGGATGATGGGAAGCTACCCTCTCTGGAGGGCAATCCCAGTCTCGTCT 1450
1460 1470 1480 1490 1500
· ... I .... I .... I .... I .... I .... I .... I .... I .... I .... I
Angora 1 TGCAGATCAAACCTTTCAAGGTGAAGATCGAGGTGCGCCAGGCCTGGAAG 1500
Goat TGCAGATCAAACCTTTCAAGGTGAAGATCGAGGTGCGCCAGGCCTGGAAG 1500
Angora 2 TGCAGATCAAACCTTTCAAGGTGAAGATCGAGGTGCGCCAGGCCTGGAAG 1500
1510 1520 1530
· ... I .... I .... I .... I .... I .... I
Angora 1 GAAGCCCAGGCTGAGGGTAGCACCTCATGA 1530
Goat GAAGCCCAGGCTGAGGGTAGCACCTCATGA 1530
Angora 2 GAAGCCCAGGCTGAGGGTAGCACCTCATGA 1530
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APPENDIXC
Angora 1 and Angora 2 represent the two CYP17 cDNA sequences and genomic represents
the partial Angora goat genomic CYP17 sequence.
ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
10 20 30 40 50
· ... I .... I .... I .... I .... I .... I .•.. I .... I .... I .... I
-------------------------------------------------- 1AAGGNTCCCGMCCCCCCCCGSCAAATTTTAAAAAGGGCCCAAGTGTTTTC 50
-------------------------------------------------- 1
60 70 80 90 100
· ... I .... I .... I .... I .... I .... I .... I .... I .... I .... I
-------------------------------------------------- 1TCCACTTCCNACAAGTTCATGGNTCCTGAAGAGCNTCCNTCCAATTCCTT 100
-------------------------------------------------- 1
110 120 130 140 150
· ... I .... I .... I .... I .... I .... I .... I .... I .... I .... I
-------------------------------------------------- 1TATTTTCCAAAGTGGAAGAAMCCNTTTGTGTCTACAGTTTGGGTNANAGT 150
-------------------------------------------------- 1
160 170 180 190 200
· ... I .... I .... I .... I .... I .... I .... I .... I .... I .... I
-------------------------------------------------- 1ATGCCAGGGGTTGCAANATGGGGCTCCTTCCTCTTTCATCGTCTCCCAAT 200
-------------------------------------------------- 1
210 220 230 240 250
· ... I .... I .... I .... I .... I .... I .... I .... I .... I .... I
ANGORA 1 -----------------GAGAACTTCACCAGCGACTCCATCACTAACTTGCTGC 37
GENOMIC CTCACCCAACCAGGAGAACTTCACCAGCGACTCCATCACTAACTTGCTGC 250
ANGORA 2 -------------GAGAACTTCACCAGCGACTCCATCACTAACTTGCTGC 37
ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
260 270 280 290 300
· ... I .... I .... I .... I .... I ...• I ••.. I .... I .••. I .... I
ACATACTGATGCAAGCCAAGGTGAATGCAGACAATAACAACGCTGGCCCA 87
ACATACTGATGCAAGCCAAGGTGAATGCAGACAATAACAACGCTGGCCCA 300
ACATACTGATGCAAGCCAAGGTGAATGCAGACAATAACAACGCTGGCCCA 87
310 320 330 340 350
· ... I .... I .... I .... I .... I .... I .... I .... I .•.• I .... I
GACCAGGATTCAAAGCTGCTTTCAAACAGACACATGCTCGCTACCATAGC 137
GACCAGGATTCAAAGCTGCTTTCAAACAGACACATGCTCGCTACCATAGC 350
GACCAGGATTCAAAGCTGCTTTCAAACAGACACATGCTCGCTACCATAGC 137
360 370 380 390 400
· ... I .... I .... I .... I .... I ...• I .•.. I .... I .... I .... I
GGACATCTTCGGGGCTGGTGTGGAGACCACCACCTCTGTGATAAAGTGGA 187
GGACATCTTCGGGGCTGGTGTGGAGACCACCACCTCTGTGATAAAGTGGA 400
GGACATCTTCGGGGCTGGTGTGGAGACCACCACCTCTGTGATAAAGTGGA 187
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ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
101
410 420 430 440 450
· ... I .... I .... I .... I .... I .... I .... I .... I .... I .... I
TCGTGGCCTACCTGCTACACCATCCTTCG--------------------- 216
TCGTGGCCTACCTGCTACACCATCCTTCGGTGAGTTTCTCTCCACCCGAG 450
TCGTGGCCTACCTGCTACACCATCCTTCG--------------------- 216
460 470 480 490 500
· ... I .... I .... I .... I .... I .... I .... I .... I .... I .... I
-------------------------------------------------- 216CCTTCCCAAGCACTCTTGACCCCAGGCACTCTCACTTCTSYYCCAGAGAA 500
-------------------------------------------------- 216
510 520 530 540 550
· ... I .... I .... I .... I .... I .... I .... I .... I .... I .... I
-------------------------------------------------- 216AGGGAGAGTCAGTACCTCGGGGTTTCTTTGCAGGATGCCTGGGCTGAAGC 550
-------------------------------------------------- 216
560 570 580 590 600
· ... I .... I .... I .... I .... I .... I .... I .... I •... I .... I
-------------------------------------------------- 216ACCCTTTGCCCAAGCAGTGGTTGGCTCTCGTCCTTCGGTGGAGCTGCCCC 600
-------------------------------------------------- 216
610 620 630 640 650
· ... I .... I .... I .... I .... I .... I .... I .... I .... I .... I
-------------------------------------------------- 216ATCTTCTGCAAGCAAAGCCGGGGTTGTAGAGCCACCACTGGGAAGGGTCT 650
-------------------------------------------------- 216
660 670 680 690 700
· ... I .... I .... I .... I .... I .... I .... I .... I .... I .... I
-------------------------------------------------- 216TGCCCTTTTGGGTGTGACAGTAGGATTCTTCTAAGCCCTTGCTTCTCCTG 700
-------------------------------------------------- 216
710 720 730 740 750
· ... I .... I .... I .... I .... I .... I .... I .... I .... I .... I
GENOMIC
ANGORA 2
ANGORA 1 -----------------------------------------------TTGAAGA 223
-------------------------------------------TTGAAGA 223
ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
GGCTGATACACCCTGGTGACATCCACCCTGTTCTMGCCCTCAGTTGAAGA 750
760 770 780 790 800
· ..• I .... I .•.. I .... I .... I .... I .... I .... I .... I .... I
AGAGGATCCAGGATAGCATTGACCAGAATATAGGTTTCAATCGCACCCCA 273
AGAGGATCCAGGATAGCATTMACCAGAATATAGGTTTCAATCGCACCCCA 800
AGAGGATCCAGGATAGCATTGACCAGAATATAGGTTTCAATCGCACCCCA 273
810 820 830 840 850
· ... I .... I .... I .... I .... I .... I .... I .... I .... I .... I
ACCATCAGTGACCGGAACTGCCTTGTCCTGCTGGAGGCGACCATCCGAGA 323
ACCATCAGTGACCGGAACTGCCTTGTCCTGCTGGAGGCGACCATCCGAGA 850
ACCATCAGTGACCGGAACTGCCTTGTCCTGCTGGAGGCAACCATCCGAGA 323
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ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
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860 870 880 890 900
.... I .... I .... I .... I .... I .... I .... I .... I .... I .... I
GGTGCTCCGAATCCGGCCTGTGGCCCCTATGCTGATCCCCCACAAGGCTA 373
GGTGCTCCGAATCCGGCCTGTGGCCCCTATGCTGATCCCCCACAAGGCTA 900
GGTGCTCCGAATCCGGCCTGTGGCCCCTATGCTGATCCCCCACAAGGCTA 373
910 920 930 940 950
· ... I .... I .... I .... I •... I .... I .... I .... I .... I .... I
TCATTGACTCCAG------------------------------------- 386
TCATTGACTCCAGGTGTGCCTTCCCTTCCAGGGAACATTCAACCCACCTG 950
TCATTGACTCCAG------------------------------------- 386
960 970 980 990 1000
· ... I .... I .... I .... I .... I .... I .... I .... I .... I .... I
-------------------------------------------------- 386GGCCCTTTCCCCAAGNAATTTGACTTNTTCCAAGCTGGCTGGTCAAACCT 1000
-------------------------------------------------- 386
1010 1020 1030 1040 1050
· ... I .... I .... I .... I .... I .... I .... I .... I .... I .... I
-------------------------------------------------- 386AACACTGACAACCGATCMTCCTACCCATGACCCTACTGACMAGTGTGTCT 1050
-------------------------------------------------- 386
1060 1070 1080 1090 1100
· ... I .... I .... I .... I .... I .... I .... I .... I .... I .... I
-------------------------------------------------- 386TCTACCCACTGACACTCACTCACCCATCGACCTGACCTCCCTCAGAAGCT 1100
-------------------------------------------------- 386
1110 1120 1130 1140 1150
· ... I .... I .... I .... I .... I .... I .... I .... I •... I .... I
-------------------------------------------------- 386GCCTGCCGCCTGGGAGACATGTGCTCCTACCCAGTCCAAAAGCTGCGACA 1150
-------------------------------------------------- 386
1160 1170 1180 1190 1200
· ... I .... I .... I .... I .... I .... I .... I .... I .... I .... I
-------------------------------------------------- 386CACACACACACGCACACACACACACATTYATGCACACACGCAGCAKCTCC 1200
-------------------------------------------------- 386
12~0 1220 1230 1240 1250
· ... I .... I .... I .... I .... I .... I .... I .... I .... I .... I
-------------------------------------------------- 386ATATGCACACCCACAGGCCCTGACAGACACACAAGTGTTGATCCCAAGTG 1250
-------------------------------------------------- 386
1260 1270 1280 1290 1300
· ... I .... I .... I .... I .... I .... I .... I .... I .... I .... I
-------------------------------------------------- 386CTAGTCAGGAAGAGAGGGCTGGATTCACATTCAATCTGGCARAAGCTGAG 1300
-------------------------------------------------- 386
1310 1320 1330 1340 1350
· ..• I .... I .... I .... I .... I .... I .... I .... I .•.. I .... I
-------------------------------------------------- 386GAGAAGATGCAGGAGTGGGCATGAGGGAGTGGYATGAGGGAGCAAAGGAC 1350
-------------------------------------------------- 386
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ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
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1360 1370 1380 1390 1400
· ... I .... I .... I .... I .... I .... I .... I .... I .... I .... I
-------------------------------------------------- 386TYTTTTCCCCAGGGTRGGGACCACGGAGACTTGGGGCAGAGCAGGTGGGG 1400
-------------------------------------------------- 386
1410 1420 1430 1440 1450
· ... I .... I .... I .... I .... I .... I .... I .... I .... I .... I----------------------------------------------CATT 390AAGGACAATACTCCAGACCCTCTTTTCCTCTCCCTCTSTGGGGCAGCATT 1450----------------------------------------------CATT 390
1460 1470 1480 1490 1500
· ... I .... I .... I .... I .... I .... I .... I .... I .... I .... I
GGCGACCTTACCATTGACAAGGGCACAGACGTTGTGGTCAACCTGTGGGC 440
GGCGACCTTACCATTGACARGGGCACAGACKTTGTGGTCAACCTGTGGGC 1500
GGCGACCTTACCATTGACAAGGGCACAGACGTTGTGGTCAACCTGTGGGC 440
1510 1520 1530 1540 1550
· ... I .... I .... I .... I .... I .... I .... I .... I .... I .... I
ACTGCATCACAATGAGAAGGAGTGGCAGCAGCCCGACCTGTTCATGCCCG 490
ACTGYATCACAATGAGAAGGAGTGGCAGCAGCCCGACCTGTTCATGCCCG 1550
ACTGCATCACAATGAGAAGGAGTGGCAGCAGCCCGACCTGTTCATGCCCG 490
1560 1570 1580 1590 1600
· ... I .... I .... I .... I .... I .... I .... I .... I .... I .... I
-------------------------------------------------- 490GTGAGTCCCTGTTCTGTCCTGCCCCCTGGCCACACAGCCCYCTSTGTGCC 1600
-------------------------------------------------- 490
1610 1620 1630 1640 1650
· ... I .... I .... I .... I .... I ••.. I .... I .... I .... I .... I
-------------------------------------------------- 490CACCTCTCCAGCATTGCTTCCTTSTGCCAAAGCTTCTACTAGAAGACTTC 1650
-------------------------------------------------- 490
1660 1670 1680 1690 1700
· ... I .... I .... I .... I .... I .... I .... I .... I .... I .... I
-------------------------------------------------- 490CTGACTCCCACTACATGGGACCTGTTGACACCCCTTAGCCTACCCGACAC 1700
-------------------------------------------------- 490
1710 1720 1730 1740 1750
· ... I .... I ..•• I .... I .... I .... I .... I .... I .... I .... I
-------------------------------------------------- 490TTACCCAGAATTNTTCAMCAGNTGGGGTTTCCCNATTTCCCCTTCCCACM 1750
-------------------------------------------------- 490
1760 1770 1780 1790 1800
· ... I .... I .... I .... I .... I .... I .... I .... I .... I .... I
-------------------------------------------------- 490AAATTGAAAGGTTCTTTTTNTAANAAGGCCCAAAAGGAATAMMTTTCCTT 1800
-------------------------------------------------- 490
1810 1820 1830 1840 1850
· ... I .... I .... I .•.. I .... I •••. I .... I .... I .•.. I .... I
-------------------------------------------------- 490GMAAAMTCAGCCCCNTCCCNMGTGGATGGGGCCATTTNMATT.MTTTAAAN 1850
-------------------------------------------------- 490
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ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
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1860 1870 1880 1890 1900
· ... I .... I .... I .... I .... I .... I ..•. I .... I .•.. I .... I
-------------------------------------------------- 490AMNCNTTTTMWCCNTTTTTAAANATTCNATCTTTTTTTGTGTGATTAAGG 1900
-------------------------------------------------- 490
1910 1920 1930 1940 1950
· ... I .... I .... I .... I .... I .... I .... I .... I .... I .... I
-------------------------------------------------- 490CCTNCTTNANAGMAGGGCATTWATTTCTCNWWAAGATTGMCGCCCCCCCA 1950
-------------------------------------------------- 490
1960 1970 1980 1990 2000
· ... I .... I .... I .... I .... I .... I .... I .... I .... I .... I
-------------------------------------------------- 490AATAAGGCTGTCCNCCTTCCCAGAMTGGGGCTCCCCARGCARGGCCTTGT 2000
-------------------------------------------------- 490
2010 2020 2030 2040 2050
· ... I .... I .... I .... I .... I .... I .... I .... I .... I .... I
-------------------------------------------------- 490CCTCCCCCYAGTCCTCTACTGACCCTGGCCTGGCCCCTGGCTGATGCCTC 2050
-------------------------------------------------- 490
2060 2070 2080 2090 2100
· ... I .... I .... I .... I .... I .... I .... I .... I .... I .... I
------------------------AGCGCTTCTTGGACCCCACGGGGACA 516
TCCATGGCCTCCCCGTTTCCACAGAGCGCTTCTTGGACCCCACGGGGACA 2100
------------------------AGCGCTTCTTGGACCCCACGGGGACA 516
2110 2120 2130 2140 2150
· ... I .... I .... I .... I .... I .... I .... I .... I .... I .... I
CAACTCATCTCGCCATCGTTAAGCTACTTGCCCTTTGGAGCTGGACCCCG 566
CAACTCATCTCGCCATCGTTAAGCTACTTGCCCTTTGGAGCTGGACCCCG 2150
CAACTCATCTCGCCATCGTTAAGCTACTTGCCCTTTGGAGCTGGACCCCG 566
2160 2170 2180 2190 2200
· ... I .... I .... I .... I .... I .... I .... I .... I .... I .... I
CTCCTGTGTAGGTGAGATGCTAGCCCGCCAGGAGCTCTTCCTCTTCATGT 616
CTCCTGTGTAGGTGAGATGCTAGCCCGCCAGGAGCTCTTCCTCTTCATGT 2200
CTCCTGTGTAGGTGAGATGCTAGCCCGCCAGGAGCTCTTCCTCTTCATGT 616
2210 2220 2230 2240 2250
· ... I .... I .... I .... I .... I .... I .... I .... I .... I .... I
CCCGGCTGCTGCAGAGGTTCAACCTGGAGATCCCGGATGATGGGAAGCTA 666
CCCGGCTGCTGCAGAGGTTCAACCTGGAGATCCCGGATGATGGGAAGCTA 2250
CCCGGCTGCTGCAGAGGTTCAACCTGGAGATCCCGGATGATGGGAAGCTA 666
2260 2270 2280 2290 2300
· ... I .... I .... I .... I .•.. I .... I .•.• I .... I .... I ...• I
CCCTCTCTGGAGGGCAATCCCAGTCTCGTCTTGCAGATCAAACCTTTCAA 716
CCCTCTCTGGAGGGCAATCCCAGTCTCGTCTTGCAGATCAAACCTTTCAA 2300
CCCTCTCTGGAGGGCAATCCCAGTCTCGTCTTGCAGATCAAACCTTTCAA 716
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ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
ANGORA 1
GENOMIC
ANGORA 2
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2310 2320 2330 2340 2350
· ... I .... I .... I .... I .... I .... I .... I .... I •... I .... I
GGTGAAGATCGAGGTGCGCCAGGCCTGGAAGGAAGCCCAGGCTGAGGGTA 766
GGTGAAGATCGAGGTGCGCCAGGCCTGGAAGGAAGCCCAGGCTGAGGGTA 2350
GGTGAAGATCGAGGTGCGCCAGGCCTGGAAGGAAGCCCAGGCTGAGGGTA 766
2360 2370 2380 2390 2400
· ... I .... I .... I .... I .... I .... I .... I .... I .... I .... I
GCACCTCATGA 777
GCACCTCATGACTCCACCCTATGMGACCCCCACCCCCCACAATTAGAGCG 2400
GCACCTCATGA 777
2410
· ... I .... I .... I
777
AGCTCCCCCGCSCTC 2415
777
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Appendix D shows the conserved proline rich domain (PRD) of CYPI7. Amino acids 32 to
44 are indicated using one letter amino acid abbreviations. Angora 1 and Angora 2 represent
the PRD sequences for the AA and A+A CYP 17 genotypes respectively.
Angora 1
Capra hircus
Angora 2
Sheep
Cow
Bison
Horse
Pig
Guinea pig
Rat
Baboon
Human
32333435 363738394041 424344 GENBANK accession number
PSLPLVGSLPFLP
PSLPLVGSLLFLP
PSLPLVGSLLFLP
PSLPLVGSLPFLP
PSLPLVGSLPFLP
PSLPLVGSLPFLP
P YL P LVG S L P F L P
PVLPVVGSLPFLP
PSLPVVGSLPFLP
PSLPLVGSLPFLP
LSLPLVGSLPFLP
LSLPLVGSLPFLP
Not available
AF251387
Not available
AF251388
NM 174304
AF292565
D88184
U41519
S75277
NM 012753
AF297650
M14564
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The numbers for each lane correspond to the goat numbers in table 6.1 except for numbers
19 - 79, which represent the goats from Grootfontein that were not phenotypically
categorized. Of these the following numbers were homozygotes: 20,23,25,39,55,56,60,
66,67,69, 72, 73, 74 and 75. Ml represents DNA marker DNAAlEco RI and DNAA/ Hind
III (Promega) and M2 represents the 1 kb Plus DNA ladder (Life Technologies).
I Ml 2 3
12 Ml 13
4 Ml 5
14 Ml 15
6 Ml 7
16 Ml
M2 8
17 M 18
9 M2 10 Ml Il
SI M2 S2 WI Ml S3
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Bl B2 Ml B3 Ml B4
30 31 32 33 34 35 36 37
50 51 Ml 52 53
Ml B4 B5 Ml 19 20 Ml 2122
108
23 24 25 Ml 26 27 28 29
38 39 Ml 40 41 42 43 44 45 46 47 48 49
545556575859606162636465666768697071 72 73 74 75 76 77 78 79
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